BindingDB Reactant_set_id Ligand SMILES Ligand InChI Ligand InChI Key BindingDB MonomerID BindingDB Ligand Name Target Name Target Source Organism According to Curator or DataSource Ki (nM) IC50 (nM) Kd (nM) EC50 (nM) kon (M-1-s-1) koff (s-1) pH Temp (C) Curation/DataSource Article DOI BindingDB Entry DOI PMID PubChem AID Patent Number Authors Date of publication Date in BindingDB Institution Link to Ligand in BindingDB Link to Target in BindingDB Link to Ligand-Target Pair in BindingDB Ligand HET ID in PDB PDB ID(s) for Ligand-Target Complex PubChem CID PubChem SID ChEBI ID of Ligand ChEMBL ID of Ligand DrugBank ID of Ligand IUPHAR_GRAC ID of Ligand KEGG ID of Ligand ZINC ID of Ligand Number of Protein Chains in Target (>1 implies a multichain complex) BindingDB Target Chain Sequence 1 PDB ID(s) of Target Chain 1 UniProt (SwissProt) Recommended Name of Target Chain 1 UniProt (SwissProt) Entry Name of Target Chain 1 UniProt (SwissProt) Primary ID of Target Chain 1 UniProt (SwissProt) Secondary ID(s) of Target Chain 1 UniProt (SwissProt) Alternative ID(s) of Target Chain 1 UniProt (TrEMBL) Submitted Name of Target Chain 1 UniProt (TrEMBL) Entry Name of Target Chain 1 UniProt (TrEMBL) Primary ID of Target Chain 1 UniProt (TrEMBL) Secondary ID(s) of Target Chain 1 UniProt (TrEMBL) Alternative ID(s) of Target Chain 1 BindingDB Target Chain Sequence 2 PDB ID(s) of Target Chain 2 UniProt (SwissProt) Recommended Name of Target Chain 2 UniProt (SwissProt) Entry Name of Target Chain 2 UniProt (SwissProt) Primary ID of Target Chain 2 UniProt (SwissProt) Secondary ID(s) of Target Chain 2 UniProt (SwissProt) Alternative ID(s) of Target Chain 2 UniProt (TrEMBL) Submitted Name of Target Chain 2 UniProt (TrEMBL) Entry Name of Target Chain 2 UniProt (TrEMBL) Primary ID of Target Chain 2 UniProt (TrEMBL) Secondary ID(s) of Target Chain 2 UniProt (TrEMBL) Alternative ID(s) of Target Chain 2 BindingDB Target Chain Sequence 3 PDB ID(s) of Target Chain 3 UniProt (SwissProt) Recommended Name of Target Chain 3 UniProt (SwissProt) Entry Name of Target Chain 3 UniProt (SwissProt) Primary ID of Target Chain 3 UniProt (SwissProt) Secondary ID(s) of Target Chain 3 UniProt (SwissProt) Alternative ID(s) of Target Chain 3 UniProt (TrEMBL) Submitted Name of Target Chain 3 UniProt (TrEMBL) Entry Name of Target Chain 3 UniProt (TrEMBL) Primary ID of Target Chain 3 UniProt (TrEMBL) Secondary ID(s) of Target Chain 3 UniProt (TrEMBL) Alternative ID(s) of Target Chain 3 BindingDB Target Chain Sequence 4 PDB ID(s) of Target Chain 4 UniProt (SwissProt) Recommended Name of Target Chain 4 UniProt (SwissProt) Entry Name of Target Chain 4 UniProt (SwissProt) Primary ID of Target Chain 4 UniProt (SwissProt) Secondary ID(s) of Target Chain 4 UniProt (SwissProt) Alternative ID(s) of Target Chain 4 UniProt (TrEMBL) Submitted Name of Target Chain 4 UniProt (TrEMBL) Entry Name of Target Chain 4 UniProt (TrEMBL) Primary ID of Target Chain 4 UniProt (TrEMBL) Secondary ID(s) of Target Chain 4 UniProt (TrEMBL) Alternative ID(s) of Target Chain 4 BindingDB Target Chain Sequence 5 PDB ID(s) of Target Chain 5 UniProt (SwissProt) Recommended Name of Target Chain 5 UniProt (SwissProt) Entry Name of Target Chain 5 UniProt (SwissProt) Primary ID of Target Chain 5 UniProt (SwissProt) Secondary ID(s) of Target Chain 5 UniProt (SwissProt) Alternative ID(s) of Target Chain 5 UniProt (TrEMBL) Submitted Name of Target Chain 5 UniProt (TrEMBL) Entry Name of Target Chain 5 UniProt (TrEMBL) Primary ID of Target Chain 5 UniProt (TrEMBL) Secondary ID(s) of Target Chain 5 UniProt (TrEMBL) Alternative ID(s) of Target Chain 5 BindingDB Target Chain Sequence 6 PDB ID(s) of Target Chain 6 UniProt (SwissProt) Recommended Name of Target Chain 6 UniProt (SwissProt) Entry Name of Target Chain 6 UniProt (SwissProt) Primary ID of Target Chain 6 UniProt (SwissProt) Secondary ID(s) of Target Chain 6 UniProt (SwissProt) Alternative ID(s) of Target Chain 6 UniProt (TrEMBL) Submitted Name of Target Chain 6 UniProt (TrEMBL) Entry Name of Target Chain 6 UniProt (TrEMBL) Primary ID of Target Chain 6 UniProt (TrEMBL) Secondary ID(s) of Target Chain 6 UniProt (TrEMBL) Alternative ID(s) of Target Chain 6 BindingDB Target Chain Sequence 7 PDB ID(s) of Target Chain 7 UniProt (SwissProt) Recommended Name of Target Chain 7 UniProt (SwissProt) Entry Name of Target Chain 7 UniProt (SwissProt) Primary ID of Target Chain 7 UniProt (SwissProt) Secondary ID(s) of Target Chain 7 UniProt (SwissProt) Alternative ID(s) of Target Chain 7 UniProt (TrEMBL) Submitted Name of Target Chain 7 UniProt (TrEMBL) Entry Name of Target Chain 7 UniProt (TrEMBL) Primary ID of Target Chain 7 UniProt (TrEMBL) Secondary ID(s) of Target Chain 7 UniProt (TrEMBL) Alternative ID(s) of Target Chain 7 BindingDB Target Chain Sequence 8 PDB ID(s) of Target Chain 8 UniProt (SwissProt) Recommended Name of Target Chain 8 UniProt (SwissProt) Entry Name of Target Chain 8 UniProt (SwissProt) Primary ID of Target Chain 8 UniProt (SwissProt) Secondary ID(s) of Target Chain 8 UniProt (SwissProt) Alternative ID(s) of Target Chain 8 UniProt (TrEMBL) Submitted Name of Target Chain 8 UniProt (TrEMBL) Entry Name of Target Chain 8 UniProt (TrEMBL) Primary ID of Target Chain 8 UniProt (TrEMBL) Secondary ID(s) of Target Chain 8 UniProt (TrEMBL) Alternative ID(s) of Target Chain 8 BindingDB Target Chain Sequence 9 PDB ID(s) of Target Chain 9 UniProt (SwissProt) Recommended Name of Target Chain 9 UniProt (SwissProt) Entry Name of Target Chain 9 UniProt (SwissProt) Primary ID of Target Chain 9 UniProt (SwissProt) Secondary ID(s) of Target Chain 9 UniProt (SwissProt) Alternative ID(s) of Target Chain 9 UniProt (TrEMBL) Submitted Name of Target Chain 9 UniProt (TrEMBL) Entry Name of Target Chain 9 UniProt (TrEMBL) Primary ID of Target Chain 9 UniProt (TrEMBL) Secondary ID(s) of Target Chain 9 UniProt (TrEMBL) Alternative ID(s) of Target Chain 9 BindingDB Target Chain Sequence 10 PDB ID(s) of Target Chain 10 UniProt (SwissProt) Recommended Name of Target Chain 10 UniProt (SwissProt) Entry Name of Target Chain 10 UniProt (SwissProt) Primary ID of Target Chain 10 UniProt (SwissProt) Secondary ID(s) of Target Chain 10 UniProt (SwissProt) Alternative ID(s) of Target Chain 10 UniProt (TrEMBL) Submitted Name of Target Chain 10 UniProt (TrEMBL) Entry Name of Target Chain 10 UniProt (TrEMBL) Primary ID of Target Chain 10 UniProt (TrEMBL) Secondary ID(s) of Target Chain 10 UniProt (TrEMBL) Alternative ID(s) of Target Chain 10 BindingDB Target Chain Sequence 11 PDB ID(s) of Target Chain 11 UniProt (SwissProt) Recommended Name of Target Chain 11 UniProt (SwissProt) Entry Name of Target Chain 11 UniProt (SwissProt) Primary ID of Target Chain 11 UniProt (SwissProt) Secondary ID(s) of Target Chain 11 UniProt (SwissProt) Alternative ID(s) of Target Chain 11 UniProt (TrEMBL) Submitted Name of Target Chain 11 UniProt (TrEMBL) Entry Name of Target Chain 11 UniProt (TrEMBL) Primary ID of Target Chain 11 UniProt (TrEMBL) Secondary ID(s) of Target Chain 11 UniProt (TrEMBL) Alternative ID(s) of Target Chain 11 BindingDB Target Chain Sequence 12 PDB ID(s) of Target Chain 12 UniProt (SwissProt) Recommended Name of Target Chain 12 UniProt (SwissProt) Entry Name of Target Chain 12 UniProt (SwissProt) Primary ID of Target Chain 12 UniProt (SwissProt) Secondary ID(s) of Target Chain 12 UniProt (SwissProt) Alternative ID(s) of Target Chain 12 UniProt (TrEMBL) Submitted Name of Target Chain 12 UniProt (TrEMBL) Entry Name of Target Chain 12 UniProt (TrEMBL) Primary ID of Target Chain 12 UniProt (TrEMBL) Secondary ID(s) of Target Chain 12 UniProt (TrEMBL) Alternative ID(s) of Target Chain 12 BindingDB Target Chain Sequence 13 PDB ID(s) of Target Chain 13 UniProt (SwissProt) Recommended Name of Target Chain 13 UniProt (SwissProt) Entry Name of Target Chain 13 UniProt (SwissProt) Primary ID of Target Chain 13 UniProt (SwissProt) Secondary ID(s) of Target Chain 13 UniProt (SwissProt) Alternative ID(s) of Target Chain 13 UniProt (TrEMBL) Submitted Name of Target Chain 13 UniProt (TrEMBL) Entry Name of Target Chain 13 UniProt (TrEMBL) Primary ID of Target Chain 13 UniProt (TrEMBL) Secondary ID(s) of Target Chain 13 UniProt (TrEMBL) Alternative ID(s) of Target Chain 13 BindingDB Target Chain Sequence 14 PDB ID(s) of Target Chain 14 UniProt (SwissProt) Recommended Name of Target Chain 14 UniProt (SwissProt) Entry Name of Target Chain 14 UniProt (SwissProt) Primary ID of Target Chain 14 UniProt (SwissProt) Secondary ID(s) of Target Chain 14 UniProt (SwissProt) Alternative ID(s) of Target Chain 14 UniProt (TrEMBL) Submitted Name of Target Chain 14 UniProt (TrEMBL) Entry Name of Target Chain 14 UniProt (TrEMBL) Primary ID of Target Chain 14 UniProt (TrEMBL) Secondary ID(s) of Target Chain 14 UniProt (TrEMBL) Alternative ID(s) of Target Chain 14 BindingDB Target Chain Sequence 15 PDB ID(s) of Target Chain 15 UniProt (SwissProt) Recommended Name of Target Chain 15 UniProt (SwissProt) Entry Name of Target Chain 15 UniProt (SwissProt) Primary ID of Target Chain 15 UniProt (SwissProt) Secondary ID(s) of Target Chain 15 UniProt (SwissProt) Alternative ID(s) of Target Chain 15 UniProt (TrEMBL) Submitted Name of Target Chain 15 UniProt (TrEMBL) Entry Name of Target Chain 15 UniProt (TrEMBL) Primary ID of Target Chain 15 UniProt (TrEMBL) Secondary ID(s) of Target Chain 15 UniProt (TrEMBL) Alternative ID(s) of Target Chain 15 BindingDB Target Chain Sequence 16 PDB ID(s) of Target Chain 16 UniProt (SwissProt) Recommended Name of Target Chain 16 UniProt (SwissProt) Entry Name of Target Chain 16 UniProt (SwissProt) Primary ID of Target Chain 16 UniProt (SwissProt) Secondary ID(s) of Target Chain 16 UniProt (SwissProt) Alternative ID(s) of Target Chain 16 UniProt (TrEMBL) Submitted Name of Target Chain 16 UniProt (TrEMBL) Entry Name of Target Chain 16 UniProt (TrEMBL) Primary ID of Target Chain 16 UniProt (TrEMBL) Secondary ID(s) of Target Chain 16 UniProt (TrEMBL) Alternative ID(s) of Target Chain 16 BindingDB Target Chain Sequence 17 PDB ID(s) of Target Chain 17 UniProt (SwissProt) Recommended Name of Target Chain 17 UniProt (SwissProt) Entry Name of Target Chain 17 UniProt (SwissProt) Primary ID of Target Chain 17 UniProt (SwissProt) Secondary ID(s) of Target Chain 17 UniProt (SwissProt) Alternative ID(s) of Target Chain 17 UniProt (TrEMBL) Submitted Name of Target Chain 17 UniProt (TrEMBL) Entry Name of Target Chain 17 UniProt (TrEMBL) Primary ID of Target Chain 17 UniProt (TrEMBL) Secondary ID(s) of Target Chain 17 UniProt (TrEMBL) Alternative ID(s) of Target Chain 17 BindingDB Target Chain Sequence 18 PDB ID(s) of Target Chain 18 UniProt (SwissProt) Recommended Name of Target Chain 18 UniProt (SwissProt) Entry Name of Target Chain 18 UniProt (SwissProt) Primary ID of Target Chain 18 UniProt (SwissProt) Secondary ID(s) of Target Chain 18 UniProt (SwissProt) Alternative ID(s) of Target Chain 18 UniProt (TrEMBL) Submitted Name of Target Chain 18 UniProt (TrEMBL) Entry Name of Target Chain 18 UniProt (TrEMBL) Primary ID of Target Chain 18 UniProt (TrEMBL) Secondary ID(s) of Target Chain 18 UniProt (TrEMBL) Alternative ID(s) of Target Chain 18 BindingDB Target Chain Sequence 19 PDB ID(s) of Target Chain 19 UniProt (SwissProt) Recommended Name of Target Chain 19 UniProt (SwissProt) Entry Name of Target Chain 19 UniProt (SwissProt) Primary ID of Target Chain 19 UniProt (SwissProt) Secondary ID(s) of Target Chain 19 UniProt (SwissProt) Alternative ID(s) of Target Chain 19 UniProt (TrEMBL) Submitted Name of Target Chain 19 UniProt (TrEMBL) Entry Name of Target Chain 19 UniProt (TrEMBL) Primary ID of Target Chain 19 UniProt (TrEMBL) Secondary ID(s) of Target Chain 19 UniProt (TrEMBL) Alternative ID(s) of Target Chain 19 BindingDB Target Chain Sequence 20 PDB ID(s) of Target Chain 20 UniProt (SwissProt) Recommended Name of Target Chain 20 UniProt (SwissProt) Entry Name of Target Chain 20 UniProt (SwissProt) Primary ID of Target Chain 20 UniProt (SwissProt) Secondary ID(s) of Target Chain 20 UniProt (SwissProt) Alternative ID(s) of Target Chain 20 UniProt (TrEMBL) Submitted Name of Target Chain 20 UniProt (TrEMBL) Entry Name of Target Chain 20 UniProt (TrEMBL) Primary ID of Target Chain 20 UniProt (TrEMBL) Secondary ID(s) of Target Chain 20 UniProt (TrEMBL) Alternative ID(s) of Target Chain 20 BindingDB Target Chain Sequence 21 PDB ID(s) of Target Chain 21 UniProt (SwissProt) Recommended Name of Target Chain 21 UniProt (SwissProt) Entry Name of Target Chain 21 UniProt (SwissProt) Primary ID of Target Chain 21 UniProt (SwissProt) Secondary ID(s) of Target Chain 21 UniProt (SwissProt) Alternative ID(s) of Target Chain 21 UniProt (TrEMBL) Submitted Name of Target Chain 21 UniProt (TrEMBL) Entry Name of Target Chain 21 UniProt (TrEMBL) Primary ID of Target Chain 21 UniProt (TrEMBL) Secondary ID(s) of Target Chain 21 UniProt (TrEMBL) Alternative ID(s) of Target Chain 21 BindingDB Target Chain Sequence 22 PDB ID(s) of Target Chain 22 UniProt (SwissProt) Recommended Name of Target Chain 22 UniProt (SwissProt) Entry Name of Target Chain 22 UniProt (SwissProt) Primary ID of Target Chain 22 UniProt (SwissProt) Secondary ID(s) of Target Chain 22 UniProt (SwissProt) Alternative ID(s) of Target Chain 22 UniProt (TrEMBL) Submitted Name of Target Chain 22 UniProt (TrEMBL) Entry Name of Target Chain 22 UniProt (TrEMBL) Primary ID of Target Chain 22 UniProt (TrEMBL) Secondary ID(s) of Target Chain 22 UniProt (TrEMBL) Alternative ID(s) of Target Chain 22 BindingDB Target Chain Sequence 23 PDB ID(s) of Target Chain 23 UniProt (SwissProt) Recommended Name of Target Chain 23 UniProt (SwissProt) Entry Name of Target Chain 23 UniProt (SwissProt) Primary ID of Target Chain 23 UniProt (SwissProt) Secondary ID(s) of Target Chain 23 UniProt (SwissProt) Alternative ID(s) of Target Chain 23 UniProt (TrEMBL) Submitted Name of Target Chain 23 UniProt (TrEMBL) Entry Name of Target Chain 23 UniProt (TrEMBL) Primary ID of Target Chain 23 UniProt (TrEMBL) Secondary ID(s) of Target Chain 23 UniProt (TrEMBL) Alternative ID(s) of Target Chain 23 BindingDB Target Chain Sequence 24 PDB ID(s) of Target Chain 24 UniProt (SwissProt) Recommended Name of Target Chain 24 UniProt (SwissProt) Entry Name of Target Chain 24 UniProt (SwissProt) Primary ID of Target Chain 24 UniProt (SwissProt) Secondary ID(s) of Target Chain 24 UniProt (SwissProt) Alternative ID(s) of Target Chain 24 UniProt (TrEMBL) Submitted Name of Target Chain 24 UniProt (TrEMBL) Entry Name of Target Chain 24 UniProt (TrEMBL) Primary ID of Target Chain 24 UniProt (TrEMBL) Secondary ID(s) of Target Chain 24 UniProt (TrEMBL) Alternative ID(s) of Target Chain 24 BindingDB Target Chain Sequence 25 PDB ID(s) of Target Chain 25 UniProt (SwissProt) Recommended Name of Target Chain 25 UniProt (SwissProt) Entry Name of Target Chain 25 UniProt (SwissProt) Primary ID of Target Chain 25 UniProt (SwissProt) Secondary ID(s) of Target Chain 25 UniProt (SwissProt) Alternative ID(s) of Target Chain 25 UniProt (TrEMBL) Submitted Name of Target Chain 25 UniProt (TrEMBL) Entry Name of Target Chain 25 UniProt (TrEMBL) Primary ID of Target Chain 25 UniProt (TrEMBL) Secondary ID(s) of Target Chain 25 UniProt (TrEMBL) Alternative ID(s) of Target Chain 25 BindingDB Target Chain Sequence 26 PDB ID(s) of Target Chain 26 UniProt (SwissProt) Recommended Name of Target Chain 26 UniProt (SwissProt) Entry Name of Target Chain 26 UniProt (SwissProt) Primary ID of Target Chain 26 UniProt (SwissProt) Secondary ID(s) of Target Chain 26 UniProt (SwissProt) Alternative ID(s) of Target Chain 26 UniProt (TrEMBL) Submitted Name of Target Chain 26 UniProt (TrEMBL) Entry Name of Target Chain 26 UniProt (TrEMBL) Primary ID of Target Chain 26 UniProt (TrEMBL) Secondary ID(s) of Target Chain 26 UniProt (TrEMBL) Alternative ID(s) of Target Chain 26 BindingDB Target Chain Sequence 27 PDB ID(s) of Target Chain 27 UniProt (SwissProt) Recommended Name of Target Chain 27 UniProt (SwissProt) Entry Name of Target Chain 27 UniProt (SwissProt) Primary ID of Target Chain 27 UniProt (SwissProt) Secondary ID(s) of Target Chain 27 UniProt (SwissProt) Alternative ID(s) of Target Chain 27 UniProt (TrEMBL) Submitted Name of Target Chain 27 UniProt (TrEMBL) Entry Name of Target Chain 27 UniProt (TrEMBL) Primary ID of Target Chain 27 UniProt (TrEMBL) Secondary ID(s) of Target Chain 27 UniProt (TrEMBL) Alternative ID(s) of Target Chain 27 BindingDB Target Chain Sequence 28 PDB ID(s) of Target Chain 28 UniProt (SwissProt) Recommended Name of Target Chain 28 UniProt (SwissProt) Entry Name of Target Chain 28 UniProt (SwissProt) Primary ID of Target Chain 28 UniProt (SwissProt) Secondary ID(s) of Target Chain 28 UniProt (SwissProt) Alternative ID(s) of Target Chain 28 UniProt (TrEMBL) Submitted Name of Target Chain 28 UniProt (TrEMBL) Entry Name of Target Chain 28 UniProt (TrEMBL) Primary ID of Target Chain 28 UniProt (TrEMBL) Secondary ID(s) of Target Chain 28 UniProt (TrEMBL) Alternative ID(s) of Target Chain 28 BindingDB Target Chain Sequence 29 PDB ID(s) of Target Chain 29 UniProt (SwissProt) Recommended Name of Target Chain 29 UniProt (SwissProt) Entry Name of Target Chain 29 UniProt (SwissProt) Primary ID of Target Chain 29 UniProt (SwissProt) Secondary ID(s) of Target Chain 29 UniProt (SwissProt) Alternative ID(s) of Target Chain 29 UniProt (TrEMBL) Submitted Name of Target Chain 29 UniProt (TrEMBL) Entry Name of Target Chain 29 UniProt (TrEMBL) Primary ID of Target Chain 29 UniProt (TrEMBL) Secondary ID(s) of Target Chain 29 UniProt (TrEMBL) Alternative ID(s) of Target Chain 29 BindingDB Target Chain Sequence 30 PDB ID(s) of Target Chain 30 UniProt (SwissProt) Recommended Name of Target Chain 30 UniProt (SwissProt) Entry Name of Target Chain 30 UniProt (SwissProt) Primary ID of Target Chain 30 UniProt (SwissProt) Secondary ID(s) of Target Chain 30 UniProt (SwissProt) Alternative ID(s) of Target Chain 30 UniProt (TrEMBL) Submitted Name of Target Chain 30 UniProt (TrEMBL) Entry Name of Target Chain 30 UniProt (TrEMBL) Primary ID of Target Chain 30 UniProt (TrEMBL) Secondary ID(s) of Target Chain 30 UniProt (TrEMBL) Alternative ID(s) of Target Chain 30 BindingDB Target Chain Sequence 31 PDB ID(s) of Target Chain 31 UniProt (SwissProt) Recommended Name of Target Chain 31 UniProt (SwissProt) Entry Name of Target Chain 31 UniProt (SwissProt) Primary ID of Target Chain 31 UniProt (SwissProt) Secondary ID(s) of Target Chain 31 UniProt (SwissProt) Alternative ID(s) of Target Chain 31 UniProt (TrEMBL) Submitted Name of Target Chain 31 UniProt (TrEMBL) Entry Name of Target Chain 31 UniProt (TrEMBL) Primary ID of Target Chain 31 UniProt (TrEMBL) Secondary ID(s) of Target Chain 31 UniProt (TrEMBL) Alternative ID(s) of Target Chain 31 BindingDB Target Chain Sequence 32 PDB ID(s) of Target Chain 32 UniProt (SwissProt) Recommended Name of Target Chain 32 UniProt (SwissProt) Entry Name of Target Chain 32 UniProt (SwissProt) Primary ID of Target Chain 32 UniProt (SwissProt) Secondary ID(s) of Target Chain 32 UniProt (SwissProt) Alternative ID(s) of Target Chain 32 UniProt (TrEMBL) Submitted Name of Target Chain 32 UniProt (TrEMBL) Entry Name of Target Chain 32 UniProt (TrEMBL) Primary ID of Target Chain 32 UniProt (TrEMBL) Secondary ID(s) of Target Chain 32 UniProt (TrEMBL) Alternative ID(s) of Target Chain 32 BindingDB Target Chain Sequence 33 PDB ID(s) of Target Chain 33 UniProt (SwissProt) Recommended Name of Target Chain 33 UniProt (SwissProt) Entry Name of Target Chain 33 UniProt (SwissProt) Primary ID of Target Chain 33 UniProt (SwissProt) Secondary ID(s) of Target Chain 33 UniProt (SwissProt) Alternative ID(s) of Target Chain 33 UniProt (TrEMBL) Submitted Name of Target Chain 33 UniProt (TrEMBL) Entry Name of Target Chain 33 UniProt (TrEMBL) Primary ID of Target Chain 33 UniProt (TrEMBL) Secondary ID(s) of Target Chain 33 UniProt (TrEMBL) Alternative ID(s) of Target Chain 33 BindingDB Target Chain Sequence 34 PDB ID(s) of Target Chain 34 UniProt (SwissProt) Recommended Name of Target Chain 34 UniProt (SwissProt) Entry Name of Target Chain 34 UniProt (SwissProt) Primary ID of Target Chain 34 UniProt (SwissProt) Secondary ID(s) of Target Chain 34 UniProt (SwissProt) Alternative ID(s) of Target Chain 34 UniProt (TrEMBL) Submitted Name of Target Chain 34 UniProt (TrEMBL) Entry Name of Target Chain 34 UniProt (TrEMBL) Primary ID of Target Chain 34 UniProt (TrEMBL) Secondary ID(s) of Target Chain 34 UniProt (TrEMBL) Alternative ID(s) of Target Chain 34 BindingDB Target Chain Sequence 35 PDB ID(s) of Target Chain 35 UniProt (SwissProt) Recommended Name of Target Chain 35 UniProt (SwissProt) Entry Name of Target Chain 35 UniProt (SwissProt) Primary ID of Target Chain 35 UniProt (SwissProt) Secondary ID(s) of Target Chain 35 UniProt (SwissProt) Alternative ID(s) of Target Chain 35 UniProt (TrEMBL) Submitted Name of Target Chain 35 UniProt (TrEMBL) Entry Name of Target Chain 35 UniProt (TrEMBL) Primary ID of Target Chain 35 UniProt (TrEMBL) Secondary ID(s) of Target Chain 35 UniProt (TrEMBL) Alternative ID(s) of Target Chain 35 BindingDB Target Chain Sequence 36 PDB ID(s) of Target Chain 36 UniProt (SwissProt) Recommended Name of Target Chain 36 UniProt (SwissProt) Entry Name of Target Chain 36 UniProt (SwissProt) Primary ID of Target Chain 36 UniProt (SwissProt) Secondary ID(s) of Target Chain 36 UniProt (SwissProt) Alternative ID(s) of Target Chain 36 UniProt (TrEMBL) Submitted Name of Target Chain 36 UniProt (TrEMBL) Entry Name of Target Chain 36 UniProt (TrEMBL) Primary ID of Target Chain 36 UniProt (TrEMBL) Secondary ID(s) of Target Chain 36 UniProt (TrEMBL) Alternative ID(s) of Target Chain 36 BindingDB Target Chain Sequence 37 PDB ID(s) of Target Chain 37 UniProt (SwissProt) Recommended Name of Target Chain 37 UniProt (SwissProt) Entry Name of Target Chain 37 UniProt (SwissProt) Primary ID of Target Chain 37 UniProt (SwissProt) Secondary ID(s) of Target Chain 37 UniProt (SwissProt) Alternative ID(s) of Target Chain 37 UniProt (TrEMBL) Submitted Name of Target Chain 37 UniProt (TrEMBL) Entry Name of Target Chain 37 UniProt (TrEMBL) Primary ID of Target Chain 37 UniProt (TrEMBL) Secondary ID(s) of Target Chain 37 UniProt (TrEMBL) Alternative ID(s) of Target Chain 37 BindingDB Target Chain Sequence 38 PDB ID(s) of Target Chain 38 UniProt (SwissProt) Recommended Name of Target Chain 38 UniProt (SwissProt) Entry Name of Target Chain 38 UniProt (SwissProt) Primary ID of Target Chain 38 UniProt (SwissProt) Secondary ID(s) of Target Chain 38 UniProt (SwissProt) Alternative ID(s) of Target Chain 38 UniProt (TrEMBL) Submitted Name of Target Chain 38 UniProt (TrEMBL) Entry Name of Target Chain 38 UniProt (TrEMBL) Primary ID of Target Chain 38 UniProt (TrEMBL) Secondary ID(s) of Target Chain 38 UniProt (TrEMBL) Alternative ID(s) of Target Chain 38 BindingDB Target Chain Sequence 39 PDB ID(s) of Target Chain 39 UniProt (SwissProt) Recommended Name of Target Chain 39 UniProt (SwissProt) Entry Name of Target Chain 39 UniProt (SwissProt) Primary ID of Target Chain 39 UniProt (SwissProt) Secondary ID(s) of Target Chain 39 UniProt (SwissProt) Alternative ID(s) of Target Chain 39 UniProt (TrEMBL) Submitted Name of Target Chain 39 UniProt (TrEMBL) Entry Name of Target Chain 39 UniProt (TrEMBL) Primary ID of Target Chain 39 UniProt (TrEMBL) Secondary ID(s) of Target Chain 39 UniProt (TrEMBL) Alternative ID(s) of Target Chain 39 BindingDB Target Chain Sequence 40 PDB ID(s) of Target Chain 40 UniProt (SwissProt) Recommended Name of Target Chain 40 UniProt (SwissProt) Entry Name of Target Chain 40 UniProt (SwissProt) Primary ID of Target Chain 40 UniProt (SwissProt) Secondary ID(s) of Target Chain 40 UniProt (SwissProt) Alternative ID(s) of Target Chain 40 UniProt (TrEMBL) Submitted Name of Target Chain 40 UniProt (TrEMBL) Entry Name of Target Chain 40 UniProt (TrEMBL) Primary ID of Target Chain 40 UniProt (TrEMBL) Secondary ID(s) of Target Chain 40 UniProt (TrEMBL) Alternative ID(s) of Target Chain 40 BindingDB Target Chain Sequence 41 PDB ID(s) of Target Chain 41 UniProt (SwissProt) Recommended Name of Target Chain 41 UniProt (SwissProt) Entry Name of Target Chain 41 UniProt (SwissProt) Primary ID of Target Chain 41 UniProt (SwissProt) Secondary ID(s) of Target Chain 41 UniProt (SwissProt) Alternative ID(s) of Target Chain 41 UniProt (TrEMBL) Submitted Name of Target Chain 41 UniProt (TrEMBL) Entry Name of Target Chain 41 UniProt (TrEMBL) Primary ID of Target Chain 41 UniProt (TrEMBL) Secondary ID(s) of Target Chain 41 UniProt (TrEMBL) Alternative ID(s) of Target Chain 41 BindingDB Target Chain Sequence 42 PDB ID(s) of Target Chain 42 UniProt (SwissProt) Recommended Name of Target Chain 42 UniProt (SwissProt) Entry Name of Target Chain 42 UniProt (SwissProt) Primary ID of Target Chain 42 UniProt (SwissProt) Secondary ID(s) of Target Chain 42 UniProt (SwissProt) Alternative ID(s) of Target Chain 42 UniProt (TrEMBL) Submitted Name of Target Chain 42 UniProt (TrEMBL) Entry Name of Target Chain 42 UniProt (TrEMBL) Primary ID of Target Chain 42 UniProt (TrEMBL) Secondary ID(s) of Target Chain 42 UniProt (TrEMBL) Alternative ID(s) of Target Chain 42 BindingDB Target Chain Sequence 43 PDB ID(s) of Target Chain 43 UniProt (SwissProt) Recommended Name of Target Chain 43 UniProt (SwissProt) Entry Name of Target Chain 43 UniProt (SwissProt) Primary ID of Target Chain 43 UniProt (SwissProt) Secondary ID(s) of Target Chain 43 UniProt (SwissProt) Alternative ID(s) of Target Chain 43 UniProt (TrEMBL) Submitted Name of Target Chain 43 UniProt (TrEMBL) Entry Name of Target Chain 43 UniProt (TrEMBL) Primary ID of Target Chain 43 UniProt (TrEMBL) Secondary ID(s) of Target Chain 43 UniProt (TrEMBL) Alternative ID(s) of Target Chain 43 BindingDB Target Chain Sequence 44 PDB ID(s) of Target Chain 44 UniProt (SwissProt) Recommended Name of Target Chain 44 UniProt (SwissProt) Entry Name of Target Chain 44 UniProt (SwissProt) Primary ID of Target Chain 44 UniProt (SwissProt) Secondary ID(s) of Target Chain 44 UniProt (SwissProt) Alternative ID(s) of Target Chain 44 UniProt (TrEMBL) Submitted Name of Target Chain 44 UniProt (TrEMBL) Entry Name of Target Chain 44 UniProt (TrEMBL) Primary ID of Target Chain 44 UniProt (TrEMBL) Secondary ID(s) of Target Chain 44 UniProt (TrEMBL) Alternative ID(s) of Target Chain 44 BindingDB Target Chain Sequence 45 PDB ID(s) of Target Chain 45 UniProt (SwissProt) Recommended Name of Target Chain 45 UniProt (SwissProt) Entry Name of Target Chain 45 UniProt (SwissProt) Primary ID of Target Chain 45 UniProt (SwissProt) Secondary ID(s) of Target Chain 45 UniProt (SwissProt) Alternative ID(s) of Target Chain 45 UniProt (TrEMBL) Submitted Name of Target Chain 45 UniProt (TrEMBL) Entry Name of Target Chain 45 UniProt (TrEMBL) Primary ID of Target Chain 45 UniProt (TrEMBL) Secondary ID(s) of Target Chain 45 UniProt (TrEMBL) Alternative ID(s) of Target Chain 45 BindingDB Target Chain Sequence 46 PDB ID(s) of Target Chain 46 UniProt (SwissProt) Recommended Name of Target Chain 46 UniProt (SwissProt) Entry Name of Target Chain 46 UniProt (SwissProt) Primary ID of Target Chain 46 UniProt (SwissProt) Secondary ID(s) of Target Chain 46 UniProt (SwissProt) Alternative ID(s) of Target Chain 46 UniProt (TrEMBL) Submitted Name of Target Chain 46 UniProt (TrEMBL) Entry Name of Target Chain 46 UniProt (TrEMBL) Primary ID of Target Chain 46 UniProt (TrEMBL) Secondary ID(s) of Target Chain 46 UniProt (TrEMBL) Alternative ID(s) of Target Chain 46 BindingDB Target Chain Sequence 47 PDB ID(s) of Target Chain 47 UniProt (SwissProt) Recommended Name of Target Chain 47 UniProt (SwissProt) Entry Name of Target Chain 47 UniProt (SwissProt) Primary ID of Target Chain 47 UniProt (SwissProt) Secondary ID(s) of Target Chain 47 UniProt (SwissProt) Alternative ID(s) of Target Chain 47 UniProt (TrEMBL) Submitted Name of Target Chain 47 UniProt (TrEMBL) Entry Name of Target Chain 47 UniProt (TrEMBL) Primary ID of Target Chain 47 UniProt (TrEMBL) Secondary ID(s) of Target Chain 47 UniProt (TrEMBL) Alternative ID(s) of Target Chain 47 BindingDB Target Chain Sequence 48 PDB ID(s) of Target Chain 48 UniProt (SwissProt) Recommended Name of Target Chain 48 UniProt (SwissProt) Entry Name of Target Chain 48 UniProt (SwissProt) Primary ID of Target Chain 48 UniProt (SwissProt) Secondary ID(s) of Target Chain 48 UniProt (SwissProt) Alternative ID(s) of Target Chain 48 UniProt (TrEMBL) Submitted Name of Target Chain 48 UniProt (TrEMBL) Entry Name of Target Chain 48 UniProt (TrEMBL) Primary ID of Target Chain 48 UniProt (TrEMBL) Secondary ID(s) of Target Chain 48 UniProt (TrEMBL) Alternative ID(s) of Target Chain 48 BindingDB Target Chain Sequence 49 PDB ID(s) of Target Chain 49 UniProt (SwissProt) Recommended Name of Target Chain 49 UniProt (SwissProt) Entry Name of Target Chain 49 UniProt (SwissProt) Primary ID of Target Chain 49 UniProt (SwissProt) Secondary ID(s) of Target Chain 49 UniProt (SwissProt) Alternative ID(s) of Target Chain 49 UniProt (TrEMBL) Submitted Name of Target Chain 49 UniProt (TrEMBL) Entry Name of Target Chain 49 UniProt (TrEMBL) Primary ID of Target Chain 49 UniProt (TrEMBL) Secondary ID(s) of Target Chain 49 UniProt (TrEMBL) Alternative ID(s) of Target Chain 49 BindingDB Target Chain Sequence 50 PDB ID(s) of Target Chain 50 UniProt (SwissProt) Recommended Name of Target Chain 50 UniProt (SwissProt) Entry Name of Target Chain 50 UniProt (SwissProt) Primary ID of Target Chain 50 UniProt (SwissProt) Secondary ID(s) of Target Chain 50 UniProt (SwissProt) Alternative ID(s) of Target Chain 50 UniProt (TrEMBL) Submitted Name of Target Chain 50 UniProt (TrEMBL) Entry Name of Target Chain 50 UniProt (TrEMBL) Primary ID of Target Chain 50 UniProt (TrEMBL) Secondary ID(s) of Target Chain 50 UniProt (TrEMBL) Alternative ID(s) of Target Chain 50 51476992 O=C(Cn1cnc2cccnc12)N1CCN(CC1)c1ccccc1-c1nc2ccccc2[nH]1 InChI=1S/C25H23N7O/c33-23(16-32-17-27-21-9-5-11-26-25(21)32)31-14-12-30(13-15-31)22-10-4-1-6-18(22)24-28-19-7-2-3-8-20(19)29-24/h1-11,17H,12-16H2,(H,28,29) VMGIBKXRQBDEKY-UHFFFAOYSA-N 50595446 CHEMBL5183256 C-X-C chemokine receptor type 3 Human 4.3 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595446&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168279505 482606298 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51476993 O=C(Cn1cnc2cccnc12)N1CCN(CC1)c1ncccc1-c1nc2ccccc2[nH]1 InChI=1S/C24H22N8O/c33-21(15-32-16-27-20-8-4-10-26-24(20)32)30-11-13-31(14-12-30)23-17(5-3-9-25-23)22-28-18-6-1-2-7-19(18)29-22/h1-10,16H,11-15H2,(H,28,29) WJJPIDLVBKROHU-UHFFFAOYSA-N 50595447 CHEMBL5177124 C-X-C chemokine receptor type 3 Human 496 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595447 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595447&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168274591 482606299 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51476994 O=C(Cn1cnc2cccnc12)N1CCN(CC1)c1nnccc1-c1nc2ccccc2[nH]1 InChI=1S/C23H21N9O/c33-20(14-32-15-25-19-6-3-8-24-23(19)32)30-10-12-31(13-11-30)22-16(7-9-26-29-22)21-27-17-4-1-2-5-18(17)28-21/h1-9,15H,10-14H2,(H,27,28) HJKDMTJWHCXJHY-UHFFFAOYSA-N 50595448 CHEMBL5205299 C-X-C chemokine receptor type 3 Human 4800 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595448 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595448&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168295351 482606300 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51476995 O=C(Cn1cnc2cccnc12)N1CCN(CC1)c1ncsc1-c1nc2ccccc2[nH]1 InChI=1S/C22H20N8OS/c31-18(12-30-13-24-17-6-3-7-23-21(17)30)28-8-10-29(11-9-28)22-19(32-14-25-22)20-26-15-4-1-2-5-16(15)27-20/h1-7,13-14H,8-12H2,(H,26,27) UAHJMMJVSLOVSN-UHFFFAOYSA-N 208647 US9266876, Reference Example 114 C-X-C chemokine receptor type 3 Human 4205 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208647 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208647&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726224 328081754 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51476996 O=C(Cn1cnc2cccnc12)N1CCN(CC1)c1cccnc1-c1nc2ccccc2[nH]1 InChI=1S/C24H22N8O/c33-21(15-32-16-27-19-7-3-10-26-24(19)32)31-13-11-30(12-14-31)20-8-4-9-25-22(20)23-28-17-5-1-2-6-18(17)29-23/h1-10,16H,11-15H2,(H,28,29) SNKCPHWBRAKKNP-UHFFFAOYSA-N 50595449 CHEMBL5197253 C-X-C chemokine receptor type 3 Human 9.3 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595449&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168286385 482606301 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51476997 O=C(Cn1cnc2cccnc12)N1CCN(CC1)c1scnc1-c1nc2ccccc2[nH]1 InChI=1S/C22H20N8OS/c31-18(12-30-13-24-17-6-3-7-23-21(17)30)28-8-10-29(11-9-28)22-19(25-14-32-22)20-26-15-4-1-2-5-16(15)27-20/h1-7,13-14H,8-12H2,(H,26,27) SCZVUUKBPVPDQO-UHFFFAOYSA-N 208547 US9266876, 14 C-X-C chemokine receptor type 3 Human 30 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208547&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71679792 328081655 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51476998 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1scnc1-c1nc2ccccc2[nH]1 InChI=1S/C23H22N8OS/c1-15-11-29(23-20(26-14-33-23)21-27-16-5-2-3-6-17(16)28-21)9-10-31(15)19(32)12-30-13-25-18-7-4-8-24-22(18)30/h2-8,13-15H,9-12H2,1H3,(H,27,28)/t15-/m1/s1 CCZJAXJXLVRTOE-OAHLLOKOSA-N 208550 US9266876, 17 C-X-C chemokine receptor type 3 Human 5.9 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208550&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71679630 328081658 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51476999 C[C@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1scnc1-c1nc2ccccc2[nH]1 InChI=1S/C23H22N8OS/c1-15-11-29(23-20(26-14-33-23)21-27-16-5-2-3-6-17(16)28-21)9-10-31(15)19(32)12-30-13-25-18-7-4-8-24-22(18)30/h2-8,13-15H,9-12H2,1H3,(H,27,28)/t15-/m0/s1 CCZJAXJXLVRTOE-HNNXBMFYSA-N 208580 US9266876, 47 C-X-C chemokine receptor type 3 Human 67 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208580&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71680142 328081687 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477000 CC[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1scnc1-c1nc2ccccc2[nH]1 InChI=1S/C24H24N8OS/c1-2-16-12-30(24-21(27-15-34-24)22-28-17-6-3-4-7-18(17)29-22)10-11-32(16)20(33)13-31-14-26-19-8-5-9-25-23(19)31/h3-9,14-16H,2,10-13H2,1H3,(H,28,29)/t16-/m1/s1 AXOCJQGAWLLMQP-MRXNPFEDSA-N 208582 US9266876, 49 C-X-C chemokine receptor type 3 Human 3.9 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208582&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71680140 328081689 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477001 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(C)nc1-c1nc2ccccc2[nH]1 InChI=1S/C24H24N8OS/c1-15-12-30(10-11-32(15)20(33)13-31-14-26-19-8-5-9-25-23(19)31)24-21(27-16(2)34-24)22-28-17-6-3-4-7-18(17)29-22/h3-9,14-15H,10-13H2,1-2H3,(H,28,29)/t15-/m1/s1 CTUWPSNEZJLVDO-OAHLLOKOSA-N 208677 US9266876, 144 C-X-C chemokine receptor type 3 Human 9.0 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208677&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726154 328081784 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477002 CCc1nc(-c2nc3ccccc3[nH]2)c(s1)N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12 InChI=1S/C25H26N8OS/c1-3-20-30-22(23-28-17-7-4-5-8-18(17)29-23)25(35-20)31-11-12-33(16(2)13-31)21(34)14-32-15-27-19-9-6-10-26-24(19)32/h4-10,15-16H,3,11-14H2,1-2H3,(H,28,29)/t16-/m1/s1 YVQHSLWAWYYPCD-MRXNPFEDSA-N 208679 US9266876, 146 C-X-C chemokine receptor type 3 Human 1.8 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208679&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89725785 328081786 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477003 CC(C)c1nc(-c2nc3ccccc3[nH]2)c(s1)N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12 InChI=1S/C26H28N8OS/c1-16(2)25-31-22(23-29-18-7-4-5-8-19(18)30-23)26(36-25)32-11-12-34(17(3)13-32)21(35)14-33-15-28-20-9-6-10-27-24(20)33/h4-10,15-17H,11-14H2,1-3H3,(H,29,30)/t17-/m1/s1 BEMATWPFDYPDGS-QGZVFWFLSA-N 208583 US9266876, 50 C-X-C chemokine receptor type 3 Human 14 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208583&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71680139 328081690 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477004 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1nc2ccccc2[nH]1)C1CC1 InChI=1S/C26H26N8OS/c1-16-13-32(11-12-34(16)21(35)14-33-15-28-20-7-4-10-27-24(20)33)26-22(31-25(36-26)17-8-9-17)23-29-18-5-2-3-6-19(18)30-23/h2-7,10,15-17H,8-9,11-14H2,1H3,(H,29,30)/t16-/m1/s1 NYCIVVXGRDGDMY-MRXNPFEDSA-N 208606 US9266876, 73 C-X-C chemokine receptor type 3 Human 9.7 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208606&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71678461 328081713 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477005 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(CO)nc1-c1nc2ccccc2[nH]1 InChI=1S/C24H24N8O2S/c1-15-11-30(9-10-32(15)20(34)12-31-14-26-18-7-4-8-25-23(18)31)24-21(29-19(13-33)35-24)22-27-16-5-2-3-6-17(16)28-22/h2-8,14-15,33H,9-13H2,1H3,(H,27,28)/t15-/m1/s1 GDZIMMMZJZDSBL-OAHLLOKOSA-N 208758 US9266876, 225 C-X-C chemokine receptor type 3 Human 171 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208758&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726443 328081865 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477006 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1nc2ccccc2[nH]1)C1COC1 InChI=1S/C26H26N8O2S/c1-16-11-32(9-10-34(16)21(35)12-33-15-28-20-7-4-8-27-24(20)33)26-22(31-25(37-26)17-13-36-14-17)23-29-18-5-2-3-6-19(18)30-23/h2-8,15-17H,9-14H2,1H3,(H,29,30)/t16-/m1/s1 RWEYPYDCLNMMCX-MRXNPFEDSA-N 208646 US9266876, 113 C-X-C chemokine receptor type 3 Human 53 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208646&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726367 328081753 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477007 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(CN(C)C)nc1-c1nc2ccccc2[nH]1 InChI=1S/C26H29N9OS/c1-17-13-33(11-12-35(17)22(36)15-34-16-28-20-9-6-10-27-25(20)34)26-23(31-21(37-26)14-32(2)3)24-29-18-7-4-5-8-19(18)30-24/h4-10,16-17H,11-15H2,1-3H3,(H,29,30)/t17-/m1/s1 CJRBJYVXACGXMC-QGZVFWFLSA-N 208756 US9266876, 223 C-X-C chemokine receptor type 3 Human 50 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208756&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726522 328081863 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477008 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1nc2ccccc2[nH]1)C(F)(F)F InChI=1S/C24H21F3N8OS/c1-14-11-33(9-10-35(14)18(36)12-34-13-29-17-7-4-8-28-21(17)34)22-19(32-23(37-22)24(25,26)27)20-30-15-5-2-3-6-16(15)31-20/h2-8,13-14H,9-12H2,1H3,(H,30,31)/t14-/m1/s1 ZXDZWWNBSQEKTQ-CQSZACIVSA-N 208584 US9266876, 51 C-X-C chemokine receptor type 3 Human 1.6 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208584&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71679146 328081691 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477009 COc1ccc(cc1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C24H23F3N6O2S/c1-15-12-31(10-11-33(15)19(34)13-32-14-29-18-4-3-9-28-21(18)32)22-20(30-23(36-22)24(25,26)27)16-5-7-17(35-2)8-6-16/h3-9,14-15H,10-13H2,1-2H3/t15-/m1/s1 XIFXGXPXGJFERZ-OAHLLOKOSA-N 50595450 CHEMBL5194504 C-X-C chemokine receptor type 3 Human 13 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595450 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595450&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168284279 482606302 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477010 COc1ccc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C23H22F3N7O2S/c1-14-11-31(8-9-33(14)18(34)12-32-13-29-16-4-3-7-27-20(16)32)21-19(30-22(36-21)23(24,25)26)15-5-6-17(35-2)28-10-15/h3-7,10,13-14H,8-9,11-12H2,1-2H3/t14-/m1/s1 JACUNCNAGINCQW-CQSZACIVSA-N 50595451 CHEMBL5198351 C-X-C chemokine receptor type 3 Human 4.1 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595451&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168287733 482606303 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477011 COc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C22H21F3N8O2S/c1-13-10-31(6-7-33(13)16(34)11-32-12-29-15-4-3-5-26-18(15)32)19-17(30-20(36-19)22(23,24)25)14-8-27-21(35-2)28-9-14/h3-5,8-9,12-13H,6-7,10-11H2,1-2H3/t13-/m1/s1 OYWKHWVAFXYSMV-CYBMUJFWSA-N 50595452 CHEMBL5181928 C-X-C chemokine receptor type 3 Human 3.8 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595452&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168273430 482606304 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477012 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C23H23F3N8O2S/c1-3-36-22-28-9-15(10-29-22)18-20(37-21(31-18)23(24,25)26)32-7-8-34(14(2)11-32)17(35)12-33-13-30-16-5-4-6-27-19(16)33/h4-6,9-10,13-14H,3,7-8,11-12H2,1-2H3/t14-/m1/s1 XBJUPTBJVOMJCO-CQSZACIVSA-N 50595453 CHEMBL5172053 C-X-C chemokine receptor type 3 Human 2.0 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595453 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595453&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168270807 482606305 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477013 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1cnc(C)nc1)C(F)(F)F InChI=1S/C22H21F3N8OS/c1-13-10-31(6-7-33(13)17(34)11-32-12-29-16-4-3-5-26-19(16)32)20-18(15-8-27-14(2)28-9-15)30-21(35-20)22(23,24)25/h3-5,8-9,12-13H,6-7,10-11H2,1-2H3/t13-/m1/s1 VLHHCRXKWPFNLU-CYBMUJFWSA-N 50595454 CHEMBL5197065 C-X-C chemokine receptor type 3 Human 3.6 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595454&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168288472 482606306 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477014 CCCc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C24H25F3N8OS/c1-3-5-18-29-10-16(11-30-18)20-22(37-23(32-20)24(25,26)27)33-8-9-35(15(2)12-33)19(36)13-34-14-31-17-6-4-7-28-21(17)34/h4,6-7,10-11,14-15H,3,5,8-9,12-13H2,1-2H3/t15-/m1/s1 SQIWTCCTICJGQD-OAHLLOKOSA-N 50595455 CHEMBL5177288 C-X-C chemokine receptor type 3 Human 3.3 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595455&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168276987 482606307 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477015 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1cnc(OCCN(C)C)nc1)C(F)(F)F InChI=1S/C25H28F3N9O2S/c1-16-13-35(7-8-37(16)19(38)14-36-15-32-18-5-4-6-29-21(18)36)22-20(33-23(40-22)25(26,27)28)17-11-30-24(31-12-17)39-10-9-34(2)3/h4-6,11-12,15-16H,7-10,13-14H2,1-3H3/t16-/m1/s1 SYQRCZRHRQEMDZ-MRXNPFEDSA-N 50595456 CHEMBL5208823 C-X-C chemokine receptor type 3 Human 6.7 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595456&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168296640 482606308 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477016 COCCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C24H25F3N8O3S/c1-15-12-33(6-7-35(15)18(36)13-34-14-31-17-4-3-5-28-20(17)34)21-19(32-22(39-21)24(25,26)27)16-10-29-23(30-11-16)38-9-8-37-2/h3-5,10-11,14-15H,6-9,12-13H2,1-2H3/t15-/m1/s1 RYHBCLVDDXPZFW-OAHLLOKOSA-N 50595457 CHEMBL5192156 C-X-C chemokine receptor type 3 Human 4.7 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595457&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168286958 482606309 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477017 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2ccccc12)C(F)(F)F InChI=1S/C24H24F3N7O2S/c1-3-36-23-28-10-16(11-29-23)20-21(37-22(31-20)24(25,26)27)32-8-9-34(15(2)12-32)19(35)13-33-14-30-17-6-4-5-7-18(17)33/h4-7,10-11,14-15H,3,8-9,12-13H2,1-2H3/t15-/m1/s1 OLVSYMSHMPDLDC-OAHLLOKOSA-N 50595458 CHEMBL5185762 C-X-C chemokine receptor type 3 Human 2.0 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595458 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595458&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168282215 482606310 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477018 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc2cccnc12)C(F)(F)F InChI=1S/C24H24F3N7O2S/c1-3-36-23-29-11-17(12-30-23)19-21(37-22(31-19)24(25,26)27)33-9-10-34(15(2)13-33)18(35)14-32-8-6-16-5-4-7-28-20(16)32/h4-8,11-12,15H,3,9-10,13-14H2,1-2H3/t15-/m1/s1 RYGFAGJTSJALSV-OAHLLOKOSA-N 50595459 CHEMBL5169888 C-X-C chemokine receptor type 3 Human 3.8 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595459&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168269369 482606311 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477019 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc2cnccc12)C(F)(F)F InChI=1S/C24H24F3N7O2S/c1-3-36-23-29-11-17(12-30-23)20-21(37-22(31-20)24(25,26)27)33-8-9-34(15(2)13-33)19(35)14-32-7-5-16-10-28-6-4-18(16)32/h4-7,10-12,15H,3,8-9,13-14H2,1-2H3/t15-/m1/s1 JKXDGMZWBPPROG-OAHLLOKOSA-N 50595460 CHEMBL5177520 C-X-C chemokine receptor type 3 Human 3.6 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595460&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168273685 482606312 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477020 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ncc2cccnc12)C(F)(F)F InChI=1S/C23H23F3N8O2S/c1-3-36-22-28-9-16(10-29-22)18-20(37-21(31-18)23(24,25)26)32-7-8-33(14(2)12-32)17(35)13-34-19-15(11-30-34)5-4-6-27-19/h4-6,9-11,14H,3,7-8,12-13H2,1-2H3/t14-/m1/s1 OHCHSHBZTNEQGO-CQSZACIVSA-N 50595461 CHEMBL5193608 C-X-C chemokine receptor type 3 Human 4.1 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595461&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168285354 482606313 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477021 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)CN1C(=O)Cc2ccccc12)C(F)(F)F InChI=1S/C25H25F3N6O3S/c1-3-37-24-29-11-17(12-30-24)21-22(38-23(31-21)25(26,27)28)32-8-9-33(15(2)13-32)20(36)14-34-18-7-5-4-6-16(18)10-19(34)35/h4-7,11-12,15H,3,8-10,13-14H2,1-2H3/t15-/m1/s1 SMAFLQUUCFSCKQ-OAHLLOKOSA-N 50595462 CHEMBL5172352 C-X-C chemokine receptor type 3 Human 3.0 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595462&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168269773 482606314 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477022 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1c2ccccc2oc1=O)C(F)(F)F InChI=1S/C24H23F3N6O4S/c1-3-36-22-28-10-15(11-29-22)19-20(38-21(30-19)24(25,26)27)31-8-9-32(14(2)12-31)18(34)13-33-16-6-4-5-7-17(16)37-23(33)35/h4-7,10-11,14H,3,8-9,12-13H2,1-2H3/t14-/m1/s1 BMVSBLODQFXGED-CQSZACIVSA-N 50595463 CHEMBL5200240 C-X-C chemokine receptor type 3 Human 3.3 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595463&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168290539 482606315 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477023 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cccn1)C(F)(F)F InChI=1S/C20H22F3N7O2S/c1-3-32-19-24-9-14(10-25-19)16-17(33-18(27-16)20(21,22)23)28-7-8-30(13(2)11-28)15(31)12-29-6-4-5-26-29/h4-6,9-10,13H,3,7-8,11-12H2,1-2H3/t13-/m1/s1 SYIPMMMMYIYKNH-CYBMUJFWSA-N 50595464 CHEMBL5177069 C-X-C chemokine receptor type 3 Human 6.9 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595464&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168272582 482606316 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477024 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nccc1C)C(F)(F)F InChI=1S/C21H24F3N7O2S/c1-4-33-20-25-9-15(10-26-20)17-18(34-19(28-17)21(22,23)24)29-7-8-30(14(3)11-29)16(32)12-31-13(2)5-6-27-31/h5-6,9-10,14H,4,7-8,11-12H2,1-3H3/t14-/m1/s1 SQQCZTRSSXULOZ-CQSZACIVSA-N 50595465 CHEMBL5190681 C-X-C chemokine receptor type 3 Human 2.0 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595465&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168280397 482606317 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477025 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc(C)n1)C(F)(F)F InChI=1S/C21H24F3N7O2S/c1-4-33-20-25-9-15(10-26-20)17-18(34-19(27-17)21(22,23)24)29-7-8-31(14(3)11-29)16(32)12-30-6-5-13(2)28-30/h5-6,9-10,14H,4,7-8,11-12H2,1-3H3/t14-/m1/s1 FNWYUHTYYMOKEC-CQSZACIVSA-N 50595466 CHEMBL5186167 C-X-C chemokine receptor type 3 Human 3.1 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595466&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168279606 482606318 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477026 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)cc1C)C(F)(F)F InChI=1S/C22H26F3N7O2S/c1-5-34-21-26-9-16(10-27-21)18-19(35-20(28-18)22(23,24)25)30-6-7-31(15(4)11-30)17(33)12-32-14(3)8-13(2)29-32/h8-10,15H,5-7,11-12H2,1-4H3/t15-/m1/s1 OJXUXNMBYAVBNZ-OAHLLOKOSA-N 50595467 CHEMBL5186627 C-X-C chemokine receptor type 3 Human 2.3 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595467&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168281055 482606319 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477027 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H25F3N8O2S/c1-5-34-20-25-8-15(9-26-20)17-18(35-19(28-17)21(22,23)24)30-6-7-31(12(2)10-30)16(33)11-32-14(4)27-13(3)29-32/h8-9,12H,5-7,10-11H2,1-4H3/t12-/m1/s1 NCYGASZSBZTJJB-GFCCVEGCSA-N 50595468 CHEMBL5190588 C-X-C chemokine receptor type 3 Human 7.0 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595468&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480455 482606320 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477028 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc(n1)C(F)(F)F)C(F)(F)F InChI=1S/C21H21F6N7O2S/c1-3-36-19-28-8-13(9-29-19)16-17(37-18(30-16)21(25,26)27)32-6-7-34(12(2)10-32)15(35)11-33-5-4-14(31-33)20(22,23)24/h4-5,8-9,12H,3,6-7,10-11H2,1-2H3/t12-/m1/s1 QSPYPBJJEIJUBY-GFCCVEGCSA-N 50595469 CHEMBL5187464 C-X-C chemokine receptor type 3 Human 3.8 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595469&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168282319 482606321 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477029 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc(n1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8O2S/c1-3-36-18-27-6-12(7-28-18)14-15(37-17(30-14)20(24,25)26)32-4-5-34(11(2)8-32)13(35)9-33-10-29-16(31-33)19(21,22)23/h6-7,10-11H,3-5,8-9H2,1-2H3/t11-/m1/s1 CQKKTUGMIMJTHL-LLVKDONJSA-N 50595470 CHEMBL5197175 C-X-C chemokine receptor type 3 Human 3.8 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595470&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168287236 482606322 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477030 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cc(Cl)cn1)C(F)(F)F InChI=1S/C20H21ClF3N7O2S/c1-3-33-19-25-6-13(7-26-19)16-17(34-18(28-16)20(22,23)24)29-4-5-31(12(2)9-29)15(32)11-30-10-14(21)8-27-30/h6-8,10,12H,3-5,9,11H2,1-2H3/t12-/m1/s1 PCGSLLVSTSRSKW-GFCCVEGCSA-N 50595471 CHEMBL5193432 C-X-C chemokine receptor type 3 Human 5.1 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595471&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168289637 482606323 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477031 COc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C20H23F3N8O2S/c1-11-9-29(5-6-30(11)15(32)10-31-13(3)26-12(2)28-31)17-16(27-18(34-17)20(21,22)23)14-7-24-19(33-4)25-8-14/h7-8,11H,5-6,9-10H2,1-4H3/t11-/m1/s1 BEGJXZQGVNJUBB-LLVKDONJSA-N 50595472 CHEMBL5181086 C-X-C chemokine receptor type 3 Human 25 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595472&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479922 482606324 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477032 CC(C)Oc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C22H27F3N8O2S/c1-12(2)35-21-26-8-16(9-27-21)18-19(36-20(29-18)22(23,24)25)31-6-7-32(13(3)10-31)17(34)11-33-15(5)28-14(4)30-33/h8-9,12-13H,6-7,10-11H2,1-5H3/t13-/m1/s1 FSVSKYZTMULUBO-CYBMUJFWSA-N 50595473 CHEMBL5175118 C-X-C chemokine receptor type 3 Human 3.4 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595473&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479878 482606325 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477033 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(OC2CCC2)nc1)C(F)(F)F InChI=1S/C23H27F3N8O2S/c1-13-11-32(7-8-33(13)18(35)12-34-15(3)29-14(2)31-34)20-19(30-21(37-20)23(24,25)26)16-9-27-22(28-10-16)36-17-5-4-6-17/h9-10,13,17H,4-8,11-12H2,1-3H3/t13-/m1/s1 UYHRPCZNDBJPKM-CYBMUJFWSA-N 50595474 CHEMBL5203452 C-X-C chemokine receptor type 3 Human 4.0 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595474&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479960 482606326 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477034 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(C)nc1)C(F)(F)F InChI=1S/C20H23F3N8OS/c1-11-9-29(5-6-30(11)16(32)10-31-14(4)26-13(3)28-31)18-17(15-7-24-12(2)25-8-15)27-19(33-18)20(21,22)23/h7-8,11H,5-6,9-10H2,1-4H3/t11-/m1/s1 MAXPGZIREDSCQL-LLVKDONJSA-N 50595475 CHEMBL5192208 C-X-C chemokine receptor type 3 Human 19 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595475&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479919 482606327 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477035 CCc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H25F3N8OS/c1-5-16-25-8-15(9-26-16)18-19(34-20(28-18)21(22,23)24)30-6-7-31(12(2)10-30)17(33)11-32-14(4)27-13(3)29-32/h8-9,12H,5-7,10-11H2,1-4H3/t12-/m1/s1 IZNYLAAYGQFRQK-GFCCVEGCSA-N 50595476 CHEMBL5183818 C-X-C chemokine receptor type 3 Human 14 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595476&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480006 482606328 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477036 CCCc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C22H27F3N8OS/c1-5-6-17-26-9-16(10-27-17)19-20(35-21(29-19)22(23,24)25)31-7-8-32(13(2)11-31)18(34)12-33-15(4)28-14(3)30-33/h9-10,13H,5-8,11-12H2,1-4H3/t13-/m1/s1 PKMSGXKNNBJYJW-CYBMUJFWSA-N 50595477 CHEMBL5195689 C-X-C chemokine receptor type 3 Human 4.4 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595477&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480457 482606329 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477037 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C1CC1)C(F)(F)F InChI=1S/C22H25F3N8OS/c1-12-10-31(6-7-32(12)17(34)11-33-14(3)28-13(2)30-33)20-18(29-21(35-20)22(23,24)25)16-8-26-19(27-9-16)15-4-5-15/h8-9,12,15H,4-7,10-11H2,1-3H3/t12-/m1/s1 ITBVWHCXAKEDFM-GFCCVEGCSA-N 50595478 CHEMBL5205683 C-X-C chemokine receptor type 3 Human 3.5 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595478&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479923 482606330 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477038 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C(C)(C)C)C(F)(F)F InChI=1S/C23H29F3N8OS/c1-13-11-32(7-8-33(13)17(35)12-34-15(3)29-14(2)31-34)19-18(30-21(36-19)23(24,25)26)16-9-27-20(28-10-16)22(4,5)6/h9-10,13H,7-8,11-12H2,1-6H3/t13-/m1/s1 JSLHIASGSJBGLL-CYBMUJFWSA-N 50595479 CHEMBL5183171 C-X-C chemokine receptor type 3 Human 8.7 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595479&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168283702 482606331 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477039 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)N1CCCC1)C(F)(F)F InChI=1S/C23H28F3N9OS/c1-14-12-33(8-9-34(14)18(36)13-35-16(3)29-15(2)31-35)20-19(30-21(37-20)23(24,25)26)17-10-27-22(28-11-17)32-6-4-5-7-32/h10-11,14H,4-9,12-13H2,1-3H3/t14-/m1/s1 DOGPUYUYHRIAAX-CQSZACIVSA-N 50595480 CHEMBL5206539 C-X-C chemokine receptor type 3 Human 3.5 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595480&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479958 482606332 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477040 COc1ccc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H24F3N7O2S/c1-12-10-29(7-8-30(12)17(32)11-31-14(3)26-13(2)28-31)19-18(27-20(34-19)21(22,23)24)15-5-6-16(33-4)25-9-15/h5-6,9,12H,7-8,10-11H2,1-4H3/t12-/m1/s1 ICSXEIGDNSDUPH-GFCCVEGCSA-N 50595481 CHEMBL5181702 C-X-C chemokine receptor type 3 Human 18 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595481&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480414 482606333 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477041 CCOc1ccc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C22H26F3N7O2S/c1-5-34-17-7-6-16(10-26-17)19-20(35-21(28-19)22(23,24)25)30-8-9-31(13(2)11-30)18(33)12-32-15(4)27-14(3)29-32/h6-7,10,13H,5,8-9,11-12H2,1-4H3/t13-/m1/s1 ZLQWYXVHVHGANW-CYBMUJFWSA-N 50595482 CHEMBL5208280 C-X-C chemokine receptor type 3 Human 8.8 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595482&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480413 482606334 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477042 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1ccc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C21H21F6N7OS/c1-11-9-32(6-7-33(11)16(35)10-34-13(3)29-12(2)31-34)18-17(30-19(36-18)21(25,26)27)14-4-5-15(28-8-14)20(22,23)24/h4-5,8,11H,6-7,9-10H2,1-3H3/t11-/m1/s1 DTKBGGWOJWTTBQ-LLVKDONJSA-N 50595483 CHEMBL5201967 C-X-C chemokine receptor type 3 Human 4.2 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595483&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480049 482606335 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477043 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(Br)nc1-c1nc2ccccc2[nH]1 InChI=1S/C23H21BrN8OS/c1-14-11-30(9-10-32(14)18(33)12-31-13-26-17-7-4-8-25-21(17)31)22-19(29-23(24)34-22)20-27-15-5-2-3-6-16(15)28-20/h2-8,13-14H,9-12H2,1H3,(H,27,28)/t14-/m1/s1 VSHOBSIPZJJYRP-CQSZACIVSA-N 208613 US9266876, 80 C-X-C chemokine receptor type 3 Human 2.8 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208613&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726625 328081720 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477044 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8OS/c1-10-8-32(4-5-33(10)14(35)9-34-12(3)29-11(2)31-34)16-15(30-18(36-16)20(24,25)26)13-6-27-17(28-7-13)19(21,22)23/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m1/s1 JENUMEXEVAAAJX-SNVBAGLBSA-N 50595484 CHEMBL5202301 C-X-C chemokine receptor type 3 Human 2.7 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595484&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 87056189 482606336 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477045 Cn1c(CN2CCN(CC2)c2ccccc2NC(=O)c2ccco2)nc2ccccc12 InChI=1S/C24H25N5O2/c1-27-20-9-4-2-7-18(20)25-23(27)17-28-12-14-29(15-13-28)21-10-5-3-8-19(21)26-24(30)22-11-6-16-31-22/h2-11,16H,12-15,17H2,1H3,(H,26,30) BBQUSIVDWLMQKD-UHFFFAOYSA-N 50595485 CHEMBL5198731 C-X-C chemokine receptor type 3 Human 372 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595485 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595485&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 16416811 482606337 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477046 Clc1cccc(c1)C(=O)Nc1ccccc1N1CCN(CC1)C(=O)Cn1cnc2cccnc12 InChI=1S/C25H23ClN6O2/c26-19-6-3-5-18(15-19)25(34)29-20-7-1-2-9-22(20)30-11-13-31(14-12-30)23(33)16-32-17-28-21-8-4-10-27-24(21)32/h1-10,15,17H,11-14,16H2,(H,29,34) POXNPPFEWKTPBX-UHFFFAOYSA-N 50595486 CHEMBL5186472 C-X-C chemokine receptor type 3 Human 1.6 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595486 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595486&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168278609 482606338 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477047 Clc1cccc(c1)C(=O)Nc1cccnc1N1CCN(CC1)C(=O)Cn1cnc2cccnc12 InChI=1S/C24H22ClN7O2/c25-18-5-1-4-17(14-18)24(34)29-20-7-3-9-27-23(20)31-12-10-30(11-13-31)21(33)15-32-16-28-19-6-2-8-26-22(19)32/h1-9,14,16H,10-13,15H2,(H,29,34) MGYITSXSLGGZTJ-UHFFFAOYSA-N 50595487 CHEMBL5183980 C-X-C chemokine receptor type 3 Human 4.2 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595487 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595487&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168282516 482606339 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477048 Clc1cccc(c1)C(=O)Nc1ncccc1N1CCN(CC1)C(=O)Cn1cnc2cccnc12 InChI=1S/C24H22ClN7O2/c25-18-5-1-4-17(14-18)24(34)29-22-20(7-3-8-26-22)30-10-12-31(13-11-30)21(33)15-32-16-28-19-6-2-9-27-23(19)32/h1-9,14,16H,10-13,15H2,(H,26,29,34) GGMGCLSFRNOFOR-UHFFFAOYSA-N 50595488 CHEMBL5179925 C-X-C chemokine receptor type 3 Human 177 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595488 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595488&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168271845 482606340 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477049 O=C(Cn1cnc2cccnc12)N1CCN(CC1)c1ccccc1-c1nc2ccccc2[nH]1 InChI=1S/C25H23N7O/c33-23(16-32-17-27-21-9-5-11-26-25(21)32)31-14-12-30(13-15-31)22-10-4-1-6-18(22)24-28-19-7-2-3-8-20(19)29-24/h1-11,17H,12-16H2,(H,28,29) VMGIBKXRQBDEKY-UHFFFAOYSA-N 50595446 CHEMBL5183256 C-X-C chemokine receptor type 3 Human 230 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595446 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595446&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168279505 482606298 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477050 O=C(Cn1cnc2cccnc12)N1CCN(CC1)c1nnccc1-c1nc2ccccc2[nH]1 InChI=1S/C23H21N9O/c33-20(14-32-15-25-19-6-3-8-24-23(19)32)30-10-12-31(13-11-30)22-16(7-9-26-29-22)21-27-17-4-1-2-5-18(17)28-21/h1-9,15H,10-14H2,(H,27,28) HJKDMTJWHCXJHY-UHFFFAOYSA-N 50595448 CHEMBL5205299 C-X-C chemokine receptor type 3 Human >21000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595448 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595448&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168295351 482606300 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477051 O=C(Cn1cnc2cccnc12)N1CCN(CC1)c1cccnc1-c1nc2ccccc2[nH]1 InChI=1S/C24H22N8O/c33-21(15-32-16-27-19-7-3-10-26-24(19)32)31-13-11-30(12-14-31)20-8-4-9-25-22(20)23-28-17-5-1-2-6-18(17)29-23/h1-10,16H,11-15H2,(H,28,29) SNKCPHWBRAKKNP-UHFFFAOYSA-N 50595449 CHEMBL5197253 C-X-C chemokine receptor type 3 Human 785 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595449 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595449&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168286385 482606301 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477052 O=C(Cn1cnc2cccnc12)N1CCN(CC1)c1scnc1-c1nc2ccccc2[nH]1 InChI=1S/C22H20N8OS/c31-18(12-30-13-24-17-6-3-7-23-21(17)30)28-8-10-29(11-9-28)22-19(25-14-32-22)20-26-15-4-1-2-5-16(15)27-20/h1-7,13-14H,8-12H2,(H,26,27) SCZVUUKBPVPDQO-UHFFFAOYSA-N 208547 US9266876, 14 C-X-C chemokine receptor type 3 Human 1437 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208547 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208547&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71679792 328081655 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477053 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1scnc1-c1nc2ccccc2[nH]1 InChI=1S/C23H22N8OS/c1-15-11-29(23-20(26-14-33-23)21-27-16-5-2-3-6-17(16)28-21)9-10-31(15)19(32)12-30-13-25-18-7-4-8-24-22(18)30/h2-8,13-15H,9-12H2,1H3,(H,27,28)/t15-/m1/s1 CCZJAXJXLVRTOE-OAHLLOKOSA-N 208550 US9266876, 17 C-X-C chemokine receptor type 3 Human 554 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208550&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71679630 328081658 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477054 CC[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1scnc1-c1nc2ccccc2[nH]1 InChI=1S/C24H24N8OS/c1-2-16-12-30(24-21(27-15-34-24)22-28-17-6-3-4-7-18(17)29-22)10-11-32(16)20(33)13-31-14-26-19-8-5-9-25-23(19)31/h3-9,14-16H,2,10-13H2,1H3,(H,28,29)/t16-/m1/s1 AXOCJQGAWLLMQP-MRXNPFEDSA-N 208582 US9266876, 49 C-X-C chemokine receptor type 3 Human 851 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208582&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71680140 328081689 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477055 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(C)nc1-c1nc2ccccc2[nH]1 InChI=1S/C24H24N8OS/c1-15-12-30(10-11-32(15)20(33)13-31-14-26-19-8-5-9-25-23(19)31)24-21(27-16(2)34-24)22-28-17-6-3-4-7-18(17)29-22/h3-9,14-15H,10-13H2,1-2H3,(H,28,29)/t15-/m1/s1 CTUWPSNEZJLVDO-OAHLLOKOSA-N 208677 US9266876, 144 C-X-C chemokine receptor type 3 Human 1060 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208677&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726154 328081784 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477056 CCc1nc(-c2nc3ccccc3[nH]2)c(s1)N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12 InChI=1S/C25H26N8OS/c1-3-20-30-22(23-28-17-7-4-5-8-18(17)29-23)25(35-20)31-11-12-33(16(2)13-31)21(34)14-32-15-27-19-9-6-10-26-24(19)32/h4-10,15-16H,3,11-14H2,1-2H3,(H,28,29)/t16-/m1/s1 YVQHSLWAWYYPCD-MRXNPFEDSA-N 208679 US9266876, 146 C-X-C chemokine receptor type 3 Human 561 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208679&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89725785 328081786 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477057 CC(C)c1nc(-c2nc3ccccc3[nH]2)c(s1)N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12 InChI=1S/C26H28N8OS/c1-16(2)25-31-22(23-29-18-7-4-5-8-19(18)30-23)26(36-25)32-11-12-34(17(3)13-32)21(35)14-33-15-28-20-9-6-10-27-24(20)33/h4-10,15-17H,11-14H2,1-3H3,(H,29,30)/t17-/m1/s1 BEMATWPFDYPDGS-QGZVFWFLSA-N 208583 US9266876, 50 C-X-C chemokine receptor type 3 Human 2468 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208583&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71680139 328081690 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477058 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1nc2ccccc2[nH]1)C1CC1 InChI=1S/C26H26N8OS/c1-16-13-32(11-12-34(16)21(35)14-33-15-28-20-7-4-10-27-24(20)33)26-22(31-25(36-26)17-8-9-17)23-29-18-5-2-3-6-19(18)30-23/h2-7,10,15-17H,8-9,11-14H2,1H3,(H,29,30)/t16-/m1/s1 NYCIVVXGRDGDMY-MRXNPFEDSA-N 208606 US9266876, 73 C-X-C chemokine receptor type 3 Human 994 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208606&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71678461 328081713 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477059 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(CO)nc1-c1nc2ccccc2[nH]1 InChI=1S/C24H24N8O2S/c1-15-11-30(9-10-32(15)20(34)12-31-14-26-18-7-4-8-25-23(18)31)24-21(29-19(13-33)35-24)22-27-16-5-2-3-6-17(16)28-22/h2-8,14-15,33H,9-13H2,1H3,(H,27,28)/t15-/m1/s1 GDZIMMMZJZDSBL-OAHLLOKOSA-N 208758 US9266876, 225 C-X-C chemokine receptor type 3 Human 3381 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208758&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726443 328081865 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477060 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1nc2ccccc2[nH]1)C1COC1 InChI=1S/C26H26N8O2S/c1-16-11-32(9-10-34(16)21(35)12-33-15-28-20-7-4-8-27-24(20)33)26-22(31-25(37-26)17-13-36-14-17)23-29-18-5-2-3-6-19(18)30-23/h2-8,15-17H,9-14H2,1H3,(H,29,30)/t16-/m1/s1 RWEYPYDCLNMMCX-MRXNPFEDSA-N 208646 US9266876, 113 C-X-C chemokine receptor type 3 Human 1154 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208646&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726367 328081753 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477061 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(CN(C)C)nc1-c1nc2ccccc2[nH]1 InChI=1S/C26H29N9OS/c1-17-13-33(11-12-35(17)22(36)15-34-16-28-20-9-6-10-27-25(20)34)26-23(31-21(37-26)14-32(2)3)24-29-18-7-4-5-8-19(18)30-24/h4-10,16-17H,11-15H2,1-3H3,(H,29,30)/t17-/m1/s1 CJRBJYVXACGXMC-QGZVFWFLSA-N 208756 US9266876, 223 C-X-C chemokine receptor type 3 Human 1154 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208756&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726522 328081863 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477062 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1nc2ccccc2[nH]1)C(F)(F)F InChI=1S/C24H21F3N8OS/c1-14-11-33(9-10-35(14)18(36)12-34-13-29-17-7-4-8-28-21(17)34)22-19(32-23(37-22)24(25,26)27)20-30-15-5-2-3-6-16(15)31-20/h2-8,13-14H,9-12H2,1H3,(H,30,31)/t14-/m1/s1 ZXDZWWNBSQEKTQ-CQSZACIVSA-N 208584 US9266876, 51 C-X-C chemokine receptor type 3 Human 70 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208584&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71679146 328081691 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477063 COc1ccc(cc1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C24H23F3N6O2S/c1-15-12-31(10-11-33(15)19(34)13-32-14-29-18-4-3-9-28-21(18)32)22-20(30-23(36-22)24(25,26)27)16-5-7-17(35-2)8-6-16/h3-9,14-15H,10-13H2,1-2H3/t15-/m1/s1 XIFXGXPXGJFERZ-OAHLLOKOSA-N 50595450 CHEMBL5194504 C-X-C chemokine receptor type 3 Human 1192 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595450 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595450&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168284279 482606302 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477064 COc1ccc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C23H22F3N7O2S/c1-14-11-31(8-9-33(14)18(34)12-32-13-29-16-4-3-7-27-20(16)32)21-19(30-22(36-21)23(24,25)26)15-5-6-17(35-2)28-10-15/h3-7,10,13-14H,8-9,11-12H2,1-2H3/t14-/m1/s1 JACUNCNAGINCQW-CQSZACIVSA-N 50595451 CHEMBL5198351 C-X-C chemokine receptor type 3 Human 270 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595451&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168287733 482606303 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477065 COc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C22H21F3N8O2S/c1-13-10-31(6-7-33(13)16(34)11-32-12-29-15-4-3-5-26-18(15)32)19-17(30-20(36-19)22(23,24)25)14-8-27-21(35-2)28-9-14/h3-5,8-9,12-13H,6-7,10-11H2,1-2H3/t13-/m1/s1 OYWKHWVAFXYSMV-CYBMUJFWSA-N 50595452 CHEMBL5181928 C-X-C chemokine receptor type 3 Human 158 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595452&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168273430 482606304 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477066 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C23H23F3N8O2S/c1-3-36-22-28-9-15(10-29-22)18-20(37-21(31-18)23(24,25)26)32-7-8-34(14(2)11-32)17(35)12-33-13-30-16-5-4-6-27-19(16)33/h4-6,9-10,13-14H,3,7-8,11-12H2,1-2H3/t14-/m1/s1 XBJUPTBJVOMJCO-CQSZACIVSA-N 50595453 CHEMBL5172053 C-X-C chemokine receptor type 3 Human 48 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595453 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595453&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168270807 482606305 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477067 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1cnc(C)nc1)C(F)(F)F InChI=1S/C22H21F3N8OS/c1-13-10-31(6-7-33(13)17(34)11-32-12-29-16-4-3-5-26-19(16)32)20-18(15-8-27-14(2)28-9-15)30-21(35-20)22(23,24)25/h3-5,8-9,12-13H,6-7,10-11H2,1-2H3/t13-/m1/s1 VLHHCRXKWPFNLU-CYBMUJFWSA-N 50595454 CHEMBL5197065 C-X-C chemokine receptor type 3 Human 104 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595454&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168288472 482606306 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477068 CCCc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C24H25F3N8OS/c1-3-5-18-29-10-16(11-30-18)20-22(37-23(32-20)24(25,26)27)33-8-9-35(15(2)12-33)19(36)13-34-14-31-17-6-4-7-28-21(17)34/h4,6-7,10-11,14-15H,3,5,8-9,12-13H2,1-2H3/t15-/m1/s1 SQIWTCCTICJGQD-OAHLLOKOSA-N 50595455 CHEMBL5177288 C-X-C chemokine receptor type 3 Human 45 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595455&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168276987 482606307 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477069 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1cnc(OCCN(C)C)nc1)C(F)(F)F InChI=1S/C25H28F3N9O2S/c1-16-13-35(7-8-37(16)19(38)14-36-15-32-18-5-4-6-29-21(18)36)22-20(33-23(40-22)25(26,27)28)17-11-30-24(31-12-17)39-10-9-34(2)3/h4-6,11-12,15-16H,7-10,13-14H2,1-3H3/t16-/m1/s1 SYQRCZRHRQEMDZ-MRXNPFEDSA-N 50595456 CHEMBL5208823 C-X-C chemokine receptor type 3 Human 381 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595456&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168296640 482606308 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477070 COCCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C24H25F3N8O3S/c1-15-12-33(6-7-35(15)18(36)13-34-14-31-17-4-3-5-28-20(17)34)21-19(32-22(39-21)24(25,26)27)16-10-29-23(30-11-16)38-9-8-37-2/h3-5,10-11,14-15H,6-9,12-13H2,1-2H3/t15-/m1/s1 RYHBCLVDDXPZFW-OAHLLOKOSA-N 50595457 CHEMBL5192156 C-X-C chemokine receptor type 3 Human 182 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595457&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168286958 482606309 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477071 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2ccccc12)C(F)(F)F InChI=1S/C24H24F3N7O2S/c1-3-36-23-28-10-16(11-29-23)20-21(37-22(31-20)24(25,26)27)32-8-9-34(15(2)12-32)19(35)13-33-14-30-17-6-4-5-7-18(17)33/h4-7,10-11,14-15H,3,8-9,12-13H2,1-2H3/t15-/m1/s1 OLVSYMSHMPDLDC-OAHLLOKOSA-N 50595458 CHEMBL5185762 C-X-C chemokine receptor type 3 Human 192 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595458 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595458&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168282215 482606310 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477072 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc2cccnc12)C(F)(F)F InChI=1S/C24H24F3N7O2S/c1-3-36-23-29-11-17(12-30-23)19-21(37-22(31-19)24(25,26)27)33-9-10-34(15(2)13-33)18(35)14-32-8-6-16-5-4-7-28-20(16)32/h4-8,11-12,15H,3,9-10,13-14H2,1-2H3/t15-/m1/s1 RYGFAGJTSJALSV-OAHLLOKOSA-N 50595459 CHEMBL5169888 C-X-C chemokine receptor type 3 Human 47 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595459&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168269369 482606311 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477073 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc2cnccc12)C(F)(F)F InChI=1S/C24H24F3N7O2S/c1-3-36-23-29-11-17(12-30-23)20-21(37-22(31-20)24(25,26)27)33-8-9-34(15(2)13-33)19(35)14-32-7-5-16-10-28-6-4-18(16)32/h4-7,10-12,15H,3,8-9,13-14H2,1-2H3/t15-/m1/s1 JKXDGMZWBPPROG-OAHLLOKOSA-N 50595460 CHEMBL5177520 C-X-C chemokine receptor type 3 Human 25 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595460&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168273685 482606312 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477074 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ncc2cccnc12)C(F)(F)F InChI=1S/C23H23F3N8O2S/c1-3-36-22-28-9-16(10-29-22)18-20(37-21(31-18)23(24,25)26)32-7-8-33(14(2)12-32)17(35)13-34-19-15(11-30-34)5-4-6-27-19/h4-6,9-11,14H,3,7-8,12-13H2,1-2H3/t14-/m1/s1 OHCHSHBZTNEQGO-CQSZACIVSA-N 50595461 CHEMBL5193608 C-X-C chemokine receptor type 3 Human 372 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595461&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168285354 482606313 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477075 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)CN1C(=O)Cc2ccccc12)C(F)(F)F InChI=1S/C25H25F3N6O3S/c1-3-37-24-29-11-17(12-30-24)21-22(38-23(31-21)25(26,27)28)32-8-9-33(15(2)13-32)20(36)14-34-18-7-5-4-6-16(18)10-19(34)35/h4-7,11-12,15H,3,8-10,13-14H2,1-2H3/t15-/m1/s1 SMAFLQUUCFSCKQ-OAHLLOKOSA-N 50595462 CHEMBL5172352 C-X-C chemokine receptor type 3 Human 29 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595462&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168269773 482606314 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477076 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1c2ccccc2oc1=O)C(F)(F)F InChI=1S/C24H23F3N6O4S/c1-3-36-22-28-10-15(11-29-22)19-20(38-21(30-19)24(25,26)27)31-8-9-32(14(2)12-31)18(34)13-33-16-6-4-5-7-17(16)37-23(33)35/h4-7,10-11,14H,3,8-9,12-13H2,1-2H3/t14-/m1/s1 BMVSBLODQFXGED-CQSZACIVSA-N 50595463 CHEMBL5200240 C-X-C chemokine receptor type 3 Human 536 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595463&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168290539 482606315 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477077 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nccc1C)C(F)(F)F InChI=1S/C21H24F3N7O2S/c1-4-33-20-25-9-15(10-26-20)17-18(34-19(28-17)21(22,23)24)29-7-8-30(14(3)11-29)16(32)12-31-13(2)5-6-27-31/h5-6,9-10,14H,4,7-8,11-12H2,1-3H3/t14-/m1/s1 SQQCZTRSSXULOZ-CQSZACIVSA-N 50595465 CHEMBL5190681 C-X-C chemokine receptor type 3 Human 289 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595465&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168280397 482606317 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477078 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc(C)n1)C(F)(F)F InChI=1S/C21H24F3N7O2S/c1-4-33-20-25-9-15(10-26-20)17-18(34-19(27-17)21(22,23)24)29-7-8-31(14(3)11-29)16(32)12-30-6-5-13(2)28-30/h5-6,9-10,14H,4,7-8,11-12H2,1-3H3/t14-/m1/s1 FNWYUHTYYMOKEC-CQSZACIVSA-N 50595466 CHEMBL5186167 C-X-C chemokine receptor type 3 Human 103 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595466&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168279606 482606318 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477079 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)cc1C)C(F)(F)F InChI=1S/C22H26F3N7O2S/c1-5-34-21-26-9-16(10-27-21)18-19(35-20(28-18)22(23,24)25)30-6-7-31(15(4)11-30)17(33)12-32-14(3)8-13(2)29-32/h8-10,15H,5-7,11-12H2,1-4H3/t15-/m1/s1 OJXUXNMBYAVBNZ-OAHLLOKOSA-N 50595467 CHEMBL5186627 C-X-C chemokine receptor type 3 Human 60 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595467&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168281055 482606319 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477080 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H25F3N8O2S/c1-5-34-20-25-8-15(9-26-20)17-18(35-19(28-17)21(22,23)24)30-6-7-31(12(2)10-30)16(33)11-32-14(4)27-13(3)29-32/h8-9,12H,5-7,10-11H2,1-4H3/t12-/m1/s1 NCYGASZSBZTJJB-GFCCVEGCSA-N 50595468 CHEMBL5190588 C-X-C chemokine receptor type 3 Human 364 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595468&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480455 482606320 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477081 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc(n1)C(F)(F)F)C(F)(F)F InChI=1S/C21H21F6N7O2S/c1-3-36-19-28-8-13(9-29-19)16-17(37-18(30-16)21(25,26)27)32-6-7-34(12(2)10-32)15(35)11-33-5-4-14(31-33)20(22,23)24/h4-5,8-9,12H,3,6-7,10-11H2,1-2H3/t12-/m1/s1 QSPYPBJJEIJUBY-GFCCVEGCSA-N 50595469 CHEMBL5187464 C-X-C chemokine receptor type 3 Human 90 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595469&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168282319 482606321 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477082 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc(n1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8O2S/c1-3-36-18-27-6-12(7-28-18)14-15(37-17(30-14)20(24,25)26)32-4-5-34(11(2)8-32)13(35)9-33-10-29-16(31-33)19(21,22)23/h6-7,10-11H,3-5,8-9H2,1-2H3/t11-/m1/s1 CQKKTUGMIMJTHL-LLVKDONJSA-N 50595470 CHEMBL5197175 C-X-C chemokine receptor type 3 Human 524 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595470&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168287236 482606322 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477083 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cc(Cl)cn1)C(F)(F)F InChI=1S/C20H21ClF3N7O2S/c1-3-33-19-25-6-13(7-26-19)16-17(34-18(28-16)20(22,23)24)29-4-5-31(12(2)9-29)15(32)11-30-10-14(21)8-27-30/h6-8,10,12H,3-5,9,11H2,1-2H3/t12-/m1/s1 PCGSLLVSTSRSKW-GFCCVEGCSA-N 50595471 CHEMBL5193432 C-X-C chemokine receptor type 3 Human 245 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595471&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168289637 482606323 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477084 COc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C20H23F3N8O2S/c1-11-9-29(5-6-30(11)15(32)10-31-13(3)26-12(2)28-31)17-16(27-18(34-17)20(21,22)23)14-7-24-19(33-4)25-8-14/h7-8,11H,5-6,9-10H2,1-4H3/t11-/m1/s1 BEGJXZQGVNJUBB-LLVKDONJSA-N 50595472 CHEMBL5181086 C-X-C chemokine receptor type 3 Human 1043 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595472&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479922 482606324 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477085 CC(C)Oc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C22H27F3N8O2S/c1-12(2)35-21-26-8-16(9-27-21)18-19(36-20(29-18)22(23,24)25)31-6-7-32(13(3)10-31)17(34)11-33-15(5)28-14(4)30-33/h8-9,12-13H,6-7,10-11H2,1-5H3/t13-/m1/s1 FSVSKYZTMULUBO-CYBMUJFWSA-N 50595473 CHEMBL5175118 C-X-C chemokine receptor type 3 Human 216 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595473&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479878 482606325 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477086 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(OC2CCC2)nc1)C(F)(F)F InChI=1S/C23H27F3N8O2S/c1-13-11-32(7-8-33(13)18(35)12-34-15(3)29-14(2)31-34)20-19(30-21(37-20)23(24,25)26)16-9-27-22(28-10-16)36-17-5-4-6-17/h9-10,13,17H,4-8,11-12H2,1-3H3/t13-/m1/s1 UYHRPCZNDBJPKM-CYBMUJFWSA-N 50595474 CHEMBL5203452 C-X-C chemokine receptor type 3 Human 306 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595474&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479960 482606326 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477087 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(C)nc1)C(F)(F)F InChI=1S/C20H23F3N8OS/c1-11-9-29(5-6-30(11)16(32)10-31-14(4)26-13(3)28-31)18-17(15-7-24-12(2)25-8-15)27-19(33-18)20(21,22)23/h7-8,11H,5-6,9-10H2,1-4H3/t11-/m1/s1 MAXPGZIREDSCQL-LLVKDONJSA-N 50595475 CHEMBL5192208 C-X-C chemokine receptor type 3 Human 610 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595475&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479919 482606327 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477088 CCc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H25F3N8OS/c1-5-16-25-8-15(9-26-16)18-19(34-20(28-18)21(22,23)24)30-6-7-31(12(2)10-30)17(33)11-32-14(4)27-13(3)29-32/h8-9,12H,5-7,10-11H2,1-4H3/t12-/m1/s1 IZNYLAAYGQFRQK-GFCCVEGCSA-N 50595476 CHEMBL5183818 C-X-C chemokine receptor type 3 Human 567 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595476&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480006 482606328 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477089 CCCc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C22H27F3N8OS/c1-5-6-17-26-9-16(10-27-17)19-20(35-21(29-19)22(23,24)25)31-7-8-32(13(2)11-31)18(34)12-33-15(4)28-14(3)30-33/h9-10,13H,5-8,11-12H2,1-4H3/t13-/m1/s1 PKMSGXKNNBJYJW-CYBMUJFWSA-N 50595477 CHEMBL5195689 C-X-C chemokine receptor type 3 Human 367 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595477&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480457 482606329 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477090 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C1CC1)C(F)(F)F InChI=1S/C22H25F3N8OS/c1-12-10-31(6-7-32(12)17(34)11-33-14(3)28-13(2)30-33)20-18(29-21(35-20)22(23,24)25)16-8-26-19(27-9-16)15-4-5-15/h8-9,12,15H,4-7,10-11H2,1-3H3/t12-/m1/s1 ITBVWHCXAKEDFM-GFCCVEGCSA-N 50595478 CHEMBL5205683 C-X-C chemokine receptor type 3 Human 674 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595478&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479923 482606330 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477091 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C(C)(C)C)C(F)(F)F InChI=1S/C23H29F3N8OS/c1-13-11-32(7-8-33(13)17(35)12-34-15(3)29-14(2)31-34)19-18(30-21(36-19)23(24,25)26)16-9-27-20(28-10-16)22(4,5)6/h9-10,13H,7-8,11-12H2,1-6H3/t13-/m1/s1 JSLHIASGSJBGLL-CYBMUJFWSA-N 50595479 CHEMBL5183171 C-X-C chemokine receptor type 3 Human 1158 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595479&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168283702 482606331 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477092 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)N1CCCC1)C(F)(F)F InChI=1S/C23H28F3N9OS/c1-14-12-33(8-9-34(14)18(36)13-35-16(3)29-15(2)31-35)20-19(30-21(37-20)23(24,25)26)17-10-27-22(28-11-17)32-6-4-5-7-32/h10-11,14H,4-9,12-13H2,1-3H3/t14-/m1/s1 DOGPUYUYHRIAAX-CQSZACIVSA-N 50595480 CHEMBL5206539 C-X-C chemokine receptor type 3 Human 352 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595480&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479958 482606332 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477093 COc1ccc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H24F3N7O2S/c1-12-10-29(7-8-30(12)17(32)11-31-14(3)26-13(2)28-31)19-18(27-20(34-19)21(22,23)24)15-5-6-16(33-4)25-9-15/h5-6,9,12H,7-8,10-11H2,1-4H3/t12-/m1/s1 ICSXEIGDNSDUPH-GFCCVEGCSA-N 50595481 CHEMBL5181702 C-X-C chemokine receptor type 3 Human 1575 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595481&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480414 482606333 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477094 CCOc1ccc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C22H26F3N7O2S/c1-5-34-17-7-6-16(10-26-17)19-20(35-21(28-19)22(23,24)25)30-8-9-31(13(2)11-30)18(33)12-32-15(4)27-14(3)29-32/h6-7,10,13H,5,8-9,11-12H2,1-4H3/t13-/m1/s1 ZLQWYXVHVHGANW-CYBMUJFWSA-N 50595482 CHEMBL5208280 C-X-C chemokine receptor type 3 Human 887 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595482&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480413 482606334 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477095 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1ccc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C21H21F6N7OS/c1-11-9-32(6-7-33(11)16(35)10-34-13(3)29-12(2)31-34)18-17(30-19(36-18)21(25,26)27)14-4-5-15(28-8-14)20(22,23)24/h4-5,8,11H,6-7,9-10H2,1-3H3/t11-/m1/s1 DTKBGGWOJWTTBQ-LLVKDONJSA-N 50595483 CHEMBL5201967 C-X-C chemokine receptor type 3 Human 860 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595483&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480049 482606335 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477096 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(Br)nc1-c1nc2ccccc2[nH]1 InChI=1S/C23H21BrN8OS/c1-14-11-30(9-10-32(14)18(33)12-31-13-26-17-7-4-8-25-21(17)31)22-19(29-23(24)34-22)20-27-15-5-2-3-6-16(15)28-20/h2-8,13-14H,9-12H2,1H3,(H,27,28)/t14-/m1/s1 VSHOBSIPZJJYRP-CQSZACIVSA-N 208613 US9266876, 80 C-X-C chemokine receptor type 3 Human 526 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208613&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726625 328081720 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477097 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8OS/c1-10-8-32(4-5-33(10)14(35)9-34-12(3)29-11(2)31-34)16-15(30-18(36-16)20(24,25)26)13-6-27-17(28-7-13)19(21,22)23/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m1/s1 JENUMEXEVAAAJX-SNVBAGLBSA-N 50595484 CHEMBL5202301 C-X-C chemokine receptor type 3 Human 204 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595484&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 87056189 482606336 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477098 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1scnc1-c1nc2ccccc2[nH]1 InChI=1S/C23H22N8OS/c1-15-11-29(23-20(26-14-33-23)21-27-16-5-2-3-6-17(16)28-21)9-10-31(15)19(32)12-30-13-25-18-7-4-8-24-22(18)30/h2-8,13-15H,9-12H2,1H3,(H,27,28)/t15-/m1/s1 CCZJAXJXLVRTOE-OAHLLOKOSA-N 208550 US9266876, 17 C-X-C chemokine receptor type 3 Human 830 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208550&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71679630 328081658 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477099 C[C@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1scnc1-c1nc2ccccc2[nH]1 InChI=1S/C23H22N8OS/c1-15-11-29(23-20(26-14-33-23)21-27-16-5-2-3-6-17(16)28-21)9-10-31(15)19(32)12-30-13-25-18-7-4-8-24-22(18)30/h2-8,13-15H,9-12H2,1H3,(H,27,28)/t15-/m0/s1 CCZJAXJXLVRTOE-HNNXBMFYSA-N 208580 US9266876, 47 C-X-C chemokine receptor type 3 Human 8030 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208580&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71680142 328081687 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477100 CC[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1scnc1-c1nc2ccccc2[nH]1 InChI=1S/C24H24N8OS/c1-2-16-12-30(24-21(27-15-34-24)22-28-17-6-3-4-7-18(17)29-22)10-11-32(16)20(33)13-31-14-26-19-8-5-9-25-23(19)31/h3-9,14-16H,2,10-13H2,1H3,(H,28,29)/t16-/m1/s1 AXOCJQGAWLLMQP-MRXNPFEDSA-N 208582 US9266876, 49 C-X-C chemokine receptor type 3 Human 604 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208582&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71680140 328081689 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477101 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(C)nc1-c1nc2ccccc2[nH]1 InChI=1S/C24H24N8OS/c1-15-12-30(10-11-32(15)20(33)13-31-14-26-19-8-5-9-25-23(19)31)24-21(27-16(2)34-24)22-28-17-6-3-4-7-18(17)29-22/h3-9,14-15H,10-13H2,1-2H3,(H,28,29)/t15-/m1/s1 CTUWPSNEZJLVDO-OAHLLOKOSA-N 208677 US9266876, 144 C-X-C chemokine receptor type 3 Human 1050 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208677&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726154 328081784 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477102 CCc1nc(-c2nc3ccccc3[nH]2)c(s1)N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12 InChI=1S/C25H26N8OS/c1-3-20-30-22(23-28-17-7-4-5-8-18(17)29-23)25(35-20)31-11-12-33(16(2)13-31)21(34)14-32-15-27-19-9-6-10-26-24(19)32/h4-10,15-16H,3,11-14H2,1-2H3,(H,28,29)/t16-/m1/s1 YVQHSLWAWYYPCD-MRXNPFEDSA-N 208679 US9266876, 146 C-X-C chemokine receptor type 3 Human 862 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208679&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89725785 328081786 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477103 CC(C)c1nc(-c2nc3ccccc3[nH]2)c(s1)N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12 InChI=1S/C26H28N8OS/c1-16(2)25-31-22(23-29-18-7-4-5-8-19(18)30-23)26(36-25)32-11-12-34(17(3)13-32)21(35)14-33-15-28-20-9-6-10-27-24(20)33/h4-10,15-17H,11-14H2,1-3H3,(H,29,30)/t17-/m1/s1 BEMATWPFDYPDGS-QGZVFWFLSA-N 208583 US9266876, 50 C-X-C chemokine receptor type 3 Human 599 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208583&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71680139 328081690 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477104 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1nc2ccccc2[nH]1)C1CC1 InChI=1S/C26H26N8OS/c1-16-13-32(11-12-34(16)21(35)14-33-15-28-20-7-4-10-27-24(20)33)26-22(31-25(36-26)17-8-9-17)23-29-18-5-2-3-6-19(18)30-23/h2-7,10,15-17H,8-9,11-14H2,1H3,(H,29,30)/t16-/m1/s1 NYCIVVXGRDGDMY-MRXNPFEDSA-N 208606 US9266876, 73 C-X-C chemokine receptor type 3 Human 745 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208606&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71678461 328081713 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477105 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(CO)nc1-c1nc2ccccc2[nH]1 InChI=1S/C24H24N8O2S/c1-15-11-30(9-10-32(15)20(34)12-31-14-26-18-7-4-8-25-23(18)31)24-21(29-19(13-33)35-24)22-27-16-5-2-3-6-17(16)28-22/h2-8,14-15,33H,9-13H2,1H3,(H,27,28)/t15-/m1/s1 GDZIMMMZJZDSBL-OAHLLOKOSA-N 208758 US9266876, 225 C-X-C chemokine receptor type 3 Human >10000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208758&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726443 328081865 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477106 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1nc2ccccc2[nH]1)C1COC1 InChI=1S/C26H26N8O2S/c1-16-11-32(9-10-34(16)21(35)12-33-15-28-20-7-4-8-27-24(20)33)26-22(31-25(37-26)17-13-36-14-17)23-29-18-5-2-3-6-19(18)30-23/h2-8,15-17H,9-14H2,1H3,(H,29,30)/t16-/m1/s1 RWEYPYDCLNMMCX-MRXNPFEDSA-N 208646 US9266876, 113 C-X-C chemokine receptor type 3 Human 6220 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208646&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726367 328081753 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477107 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(CN(C)C)nc1-c1nc2ccccc2[nH]1 InChI=1S/C26H29N9OS/c1-17-13-33(11-12-35(17)22(36)15-34-16-28-20-9-6-10-27-25(20)34)26-23(31-21(37-26)14-32(2)3)24-29-18-7-4-5-8-19(18)30-24/h4-10,16-17H,11-15H2,1-3H3,(H,29,30)/t17-/m1/s1 CJRBJYVXACGXMC-QGZVFWFLSA-N 208756 US9266876, 223 C-X-C chemokine receptor type 3 Human 2360 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208756&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726522 328081863 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477108 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1nc2ccccc2[nH]1)C(F)(F)F InChI=1S/C24H21F3N8OS/c1-14-11-33(9-10-35(14)18(36)12-34-13-29-17-7-4-8-28-21(17)34)22-19(32-23(37-22)24(25,26)27)20-30-15-5-2-3-6-16(15)31-20/h2-8,13-14H,9-12H2,1H3,(H,30,31)/t14-/m1/s1 ZXDZWWNBSQEKTQ-CQSZACIVSA-N 208584 US9266876, 51 C-X-C chemokine receptor type 3 Human 31 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208584&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 71679146 328081691 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477109 COc1ccc(cc1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C24H23F3N6O2S/c1-15-12-31(10-11-33(15)19(34)13-32-14-29-18-4-3-9-28-21(18)32)22-20(30-23(36-22)24(25,26)27)16-5-7-17(35-2)8-6-16/h3-9,14-15H,10-13H2,1-2H3/t15-/m1/s1 XIFXGXPXGJFERZ-OAHLLOKOSA-N 50595450 CHEMBL5194504 C-X-C chemokine receptor type 3 Human 131 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595450 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595450&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168284279 482606302 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477110 COc1ccc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C23H22F3N7O2S/c1-14-11-31(8-9-33(14)18(34)12-32-13-29-16-4-3-7-27-20(16)32)21-19(30-22(36-21)23(24,25)26)15-5-6-17(35-2)28-10-15/h3-7,10,13-14H,8-9,11-12H2,1-2H3/t14-/m1/s1 JACUNCNAGINCQW-CQSZACIVSA-N 50595451 CHEMBL5198351 C-X-C chemokine receptor type 3 Human 104 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595451&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168287733 482606303 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477111 COc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C22H21F3N8O2S/c1-13-10-31(6-7-33(13)16(34)11-32-12-29-15-4-3-5-26-18(15)32)19-17(30-20(36-19)22(23,24)25)14-8-27-21(35-2)28-9-14/h3-5,8-9,12-13H,6-7,10-11H2,1-2H3/t13-/m1/s1 OYWKHWVAFXYSMV-CYBMUJFWSA-N 50595452 CHEMBL5181928 C-X-C chemokine receptor type 3 Human 177 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595452&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168273430 482606304 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477112 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C23H23F3N8O2S/c1-3-36-22-28-9-15(10-29-22)18-20(37-21(31-18)23(24,25)26)32-7-8-34(14(2)11-32)17(35)12-33-13-30-16-5-4-6-27-19(16)33/h4-6,9-10,13-14H,3,7-8,11-12H2,1-2H3/t14-/m1/s1 XBJUPTBJVOMJCO-CQSZACIVSA-N 50595453 CHEMBL5172053 C-X-C chemokine receptor type 3 Human 20 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595453 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595453&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168270807 482606305 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477113 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1cnc(C)nc1)C(F)(F)F InChI=1S/C22H21F3N8OS/c1-13-10-31(6-7-33(13)17(34)11-32-12-29-16-4-3-5-26-19(16)32)20-18(15-8-27-14(2)28-9-15)30-21(35-20)22(23,24)25/h3-5,8-9,12-13H,6-7,10-11H2,1-2H3/t13-/m1/s1 VLHHCRXKWPFNLU-CYBMUJFWSA-N 50595454 CHEMBL5197065 C-X-C chemokine receptor type 3 Human 168 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595454&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168288472 482606306 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477114 CCCc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C24H25F3N8OS/c1-3-5-18-29-10-16(11-30-18)20-22(37-23(32-20)24(25,26)27)33-8-9-35(15(2)12-33)19(36)13-34-14-31-17-6-4-7-28-21(17)34/h4,6-7,10-11,14-15H,3,5,8-9,12-13H2,1-2H3/t15-/m1/s1 SQIWTCCTICJGQD-OAHLLOKOSA-N 50595455 CHEMBL5177288 C-X-C chemokine receptor type 3 Human 33 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595455&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168276987 482606307 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477115 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1cnc(OCCN(C)C)nc1)C(F)(F)F InChI=1S/C25H28F3N9O2S/c1-16-13-35(7-8-37(16)19(38)14-36-15-32-18-5-4-6-29-21(18)36)22-20(33-23(40-22)25(26,27)28)17-11-30-24(31-12-17)39-10-9-34(2)3/h4-6,11-12,15-16H,7-10,13-14H2,1-3H3/t16-/m1/s1 SYQRCZRHRQEMDZ-MRXNPFEDSA-N 50595456 CHEMBL5208823 C-X-C chemokine receptor type 3 Human 140 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595456&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168296640 482606308 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477116 COCCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C24H25F3N8O3S/c1-15-12-33(6-7-35(15)18(36)13-34-14-31-17-4-3-5-28-20(17)34)21-19(32-22(39-21)24(25,26)27)16-10-29-23(30-11-16)38-9-8-37-2/h3-5,10-11,14-15H,6-9,12-13H2,1-2H3/t15-/m1/s1 RYHBCLVDDXPZFW-OAHLLOKOSA-N 50595457 CHEMBL5192156 C-X-C chemokine receptor type 3 Human 324 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595457&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168286958 482606309 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477117 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2ccccc12)C(F)(F)F InChI=1S/C24H24F3N7O2S/c1-3-36-23-28-10-16(11-29-23)20-21(37-22(31-20)24(25,26)27)32-8-9-34(15(2)12-32)19(35)13-33-14-30-17-6-4-5-7-18(17)33/h4-7,10-11,14-15H,3,8-9,12-13H2,1-2H3/t15-/m1/s1 OLVSYMSHMPDLDC-OAHLLOKOSA-N 50595458 CHEMBL5185762 C-X-C chemokine receptor type 3 Human 49 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595458 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595458&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168282215 482606310 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477118 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc2cccnc12)C(F)(F)F InChI=1S/C24H24F3N7O2S/c1-3-36-23-29-11-17(12-30-23)19-21(37-22(31-19)24(25,26)27)33-9-10-34(15(2)13-33)18(35)14-32-8-6-16-5-4-7-28-20(16)32/h4-8,11-12,15H,3,9-10,13-14H2,1-2H3/t15-/m1/s1 RYGFAGJTSJALSV-OAHLLOKOSA-N 50595459 CHEMBL5169888 C-X-C chemokine receptor type 3 Human 47 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595459&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168269369 482606311 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477119 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc2cnccc12)C(F)(F)F InChI=1S/C24H24F3N7O2S/c1-3-36-23-29-11-17(12-30-23)20-21(37-22(31-20)24(25,26)27)33-8-9-34(15(2)13-33)19(35)14-32-7-5-16-10-28-6-4-18(16)32/h4-7,10-12,15H,3,8-9,13-14H2,1-2H3/t15-/m1/s1 JKXDGMZWBPPROG-OAHLLOKOSA-N 50595460 CHEMBL5177520 C-X-C chemokine receptor type 3 Human 23 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595460&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168273685 482606312 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477120 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ncc2cccnc12)C(F)(F)F InChI=1S/C23H23F3N8O2S/c1-3-36-22-28-9-16(10-29-22)18-20(37-21(31-18)23(24,25)26)32-7-8-33(14(2)12-32)17(35)13-34-19-15(11-30-34)5-4-6-27-19/h4-6,9-11,14H,3,7-8,12-13H2,1-2H3/t14-/m1/s1 OHCHSHBZTNEQGO-CQSZACIVSA-N 50595461 CHEMBL5193608 C-X-C chemokine receptor type 3 Human 55 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595461&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168285354 482606313 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477121 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)CN1C(=O)Cc2ccccc12)C(F)(F)F InChI=1S/C25H25F3N6O3S/c1-3-37-24-29-11-17(12-30-24)21-22(38-23(31-21)25(26,27)28)32-8-9-33(15(2)13-32)20(36)14-34-18-7-5-4-6-16(18)10-19(34)35/h4-7,11-12,15H,3,8-10,13-14H2,1-2H3/t15-/m1/s1 SMAFLQUUCFSCKQ-OAHLLOKOSA-N 50595462 CHEMBL5172352 C-X-C chemokine receptor type 3 Human 24 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595462&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168269773 482606314 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477122 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1c2ccccc2oc1=O)C(F)(F)F InChI=1S/C24H23F3N6O4S/c1-3-36-22-28-10-15(11-29-22)19-20(38-21(30-19)24(25,26)27)31-8-9-32(14(2)12-31)18(34)13-33-16-6-4-5-7-17(16)37-23(33)35/h4-7,10-11,14H,3,8-9,12-13H2,1-2H3/t14-/m1/s1 BMVSBLODQFXGED-CQSZACIVSA-N 50595463 CHEMBL5200240 C-X-C chemokine receptor type 3 Human 99 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595463&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168290539 482606315 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477123 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cccn1)C(F)(F)F InChI=1S/C20H22F3N7O2S/c1-3-32-19-24-9-14(10-25-19)16-17(33-18(27-16)20(21,22)23)28-7-8-30(13(2)11-28)15(31)12-29-6-4-5-26-29/h4-6,9-10,13H,3,7-8,11-12H2,1-2H3/t13-/m1/s1 SYIPMMMMYIYKNH-CYBMUJFWSA-N 50595464 CHEMBL5177069 C-X-C chemokine receptor type 3 Human 811 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595464&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168272582 482606316 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477124 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nccc1C)C(F)(F)F InChI=1S/C21H24F3N7O2S/c1-4-33-20-25-9-15(10-26-20)17-18(34-19(28-17)21(22,23)24)29-7-8-30(14(3)11-29)16(32)12-31-13(2)5-6-27-31/h5-6,9-10,14H,4,7-8,11-12H2,1-3H3/t14-/m1/s1 SQQCZTRSSXULOZ-CQSZACIVSA-N 50595465 CHEMBL5190681 C-X-C chemokine receptor type 3 Human 162 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595465&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168280397 482606317 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477125 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc(C)n1)C(F)(F)F InChI=1S/C21H24F3N7O2S/c1-4-33-20-25-9-15(10-26-20)17-18(34-19(27-17)21(22,23)24)29-7-8-31(14(3)11-29)16(32)12-30-6-5-13(2)28-30/h5-6,9-10,14H,4,7-8,11-12H2,1-3H3/t14-/m1/s1 FNWYUHTYYMOKEC-CQSZACIVSA-N 50595466 CHEMBL5186167 C-X-C chemokine receptor type 3 Human 70 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595466&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168279606 482606318 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477126 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)cc1C)C(F)(F)F InChI=1S/C22H26F3N7O2S/c1-5-34-21-26-9-16(10-27-21)18-19(35-20(28-18)22(23,24)25)30-6-7-31(15(4)11-30)17(33)12-32-14(3)8-13(2)29-32/h8-10,15H,5-7,11-12H2,1-4H3/t15-/m1/s1 OJXUXNMBYAVBNZ-OAHLLOKOSA-N 50595467 CHEMBL5186627 C-X-C chemokine receptor type 3 Human 87 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595467&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168281055 482606319 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477127 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H25F3N8O2S/c1-5-34-20-25-8-15(9-26-20)17-18(35-19(28-17)21(22,23)24)30-6-7-31(12(2)10-30)16(33)11-32-14(4)27-13(3)29-32/h8-9,12H,5-7,10-11H2,1-4H3/t12-/m1/s1 NCYGASZSBZTJJB-GFCCVEGCSA-N 50595468 CHEMBL5190588 C-X-C chemokine receptor type 3 Human 173 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595468&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480455 482606320 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477128 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc(n1)C(F)(F)F)C(F)(F)F InChI=1S/C21H21F6N7O2S/c1-3-36-19-28-8-13(9-29-19)16-17(37-18(30-16)21(25,26)27)32-6-7-34(12(2)10-32)15(35)11-33-5-4-14(31-33)20(22,23)24/h4-5,8-9,12H,3,6-7,10-11H2,1-2H3/t12-/m1/s1 QSPYPBJJEIJUBY-GFCCVEGCSA-N 50595469 CHEMBL5187464 C-X-C chemokine receptor type 3 Human 93 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595469&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168282319 482606321 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477129 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc(n1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8O2S/c1-3-36-18-27-6-12(7-28-18)14-15(37-17(30-14)20(24,25)26)32-4-5-34(11(2)8-32)13(35)9-33-10-29-16(31-33)19(21,22)23/h6-7,10-11H,3-5,8-9H2,1-2H3/t11-/m1/s1 CQKKTUGMIMJTHL-LLVKDONJSA-N 50595470 CHEMBL5197175 C-X-C chemokine receptor type 3 Human 118 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595470&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168287236 482606322 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477130 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cc(Cl)cn1)C(F)(F)F InChI=1S/C20H21ClF3N7O2S/c1-3-33-19-25-6-13(7-26-19)16-17(34-18(28-16)20(22,23)24)29-4-5-31(12(2)9-29)15(32)11-30-10-14(21)8-27-30/h6-8,10,12H,3-5,9,11H2,1-2H3/t12-/m1/s1 PCGSLLVSTSRSKW-GFCCVEGCSA-N 50595471 CHEMBL5193432 C-X-C chemokine receptor type 3 Human 272 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595471&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168289637 482606323 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477131 COc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C20H23F3N8O2S/c1-11-9-29(5-6-30(11)15(32)10-31-13(3)26-12(2)28-31)17-16(27-18(34-17)20(21,22)23)14-7-24-19(33-4)25-8-14/h7-8,11H,5-6,9-10H2,1-4H3/t11-/m1/s1 BEGJXZQGVNJUBB-LLVKDONJSA-N 50595472 CHEMBL5181086 C-X-C chemokine receptor type 3 Human 558 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595472&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479922 482606324 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477132 CC(C)Oc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C22H27F3N8O2S/c1-12(2)35-21-26-8-16(9-27-21)18-19(36-20(29-18)22(23,24)25)31-6-7-32(13(3)10-31)17(34)11-33-15(5)28-14(4)30-33/h8-9,12-13H,6-7,10-11H2,1-5H3/t13-/m1/s1 FSVSKYZTMULUBO-CYBMUJFWSA-N 50595473 CHEMBL5175118 C-X-C chemokine receptor type 3 Human 138 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595473&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479878 482606325 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477133 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(OC2CCC2)nc1)C(F)(F)F InChI=1S/C23H27F3N8O2S/c1-13-11-32(7-8-33(13)18(35)12-34-15(3)29-14(2)31-34)20-19(30-21(37-20)23(24,25)26)16-9-27-22(28-10-16)36-17-5-4-6-17/h9-10,13,17H,4-8,11-12H2,1-3H3/t13-/m1/s1 UYHRPCZNDBJPKM-CYBMUJFWSA-N 50595474 CHEMBL5203452 C-X-C chemokine receptor type 3 Human 78 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595474&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479960 482606326 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477134 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(C)nc1)C(F)(F)F InChI=1S/C20H23F3N8OS/c1-11-9-29(5-6-30(11)16(32)10-31-14(4)26-13(3)28-31)18-17(15-7-24-12(2)25-8-15)27-19(33-18)20(21,22)23/h7-8,11H,5-6,9-10H2,1-4H3/t11-/m1/s1 MAXPGZIREDSCQL-LLVKDONJSA-N 50595475 CHEMBL5192208 C-X-C chemokine receptor type 3 Human 578 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595475&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479919 482606327 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477135 CCc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H25F3N8OS/c1-5-16-25-8-15(9-26-16)18-19(34-20(28-18)21(22,23)24)30-6-7-31(12(2)10-30)17(33)11-32-14(4)27-13(3)29-32/h8-9,12H,5-7,10-11H2,1-4H3/t12-/m1/s1 IZNYLAAYGQFRQK-GFCCVEGCSA-N 50595476 CHEMBL5183818 C-X-C chemokine receptor type 3 Human 1430 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595476&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480006 482606328 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477136 CCCc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C22H27F3N8OS/c1-5-6-17-26-9-16(10-27-17)19-20(35-21(29-19)22(23,24)25)31-7-8-32(13(2)11-31)18(34)12-33-15(4)28-14(3)30-33/h9-10,13H,5-8,11-12H2,1-4H3/t13-/m1/s1 PKMSGXKNNBJYJW-CYBMUJFWSA-N 50595477 CHEMBL5195689 C-X-C chemokine receptor type 3 Human 258 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595477&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480457 482606329 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477137 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C1CC1)C(F)(F)F InChI=1S/C22H25F3N8OS/c1-12-10-31(6-7-32(12)17(34)11-33-14(3)28-13(2)30-33)20-18(29-21(35-20)22(23,24)25)16-8-26-19(27-9-16)15-4-5-15/h8-9,12,15H,4-7,10-11H2,1-3H3/t12-/m1/s1 ITBVWHCXAKEDFM-GFCCVEGCSA-N 50595478 CHEMBL5205683 C-X-C chemokine receptor type 3 Human 349 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595478&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479923 482606330 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477138 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C(C)(C)C)C(F)(F)F InChI=1S/C23H29F3N8OS/c1-13-11-32(7-8-33(13)17(35)12-34-15(3)29-14(2)31-34)19-18(30-21(36-19)23(24,25)26)16-9-27-20(28-10-16)22(4,5)6/h9-10,13H,7-8,11-12H2,1-6H3/t13-/m1/s1 JSLHIASGSJBGLL-CYBMUJFWSA-N 50595479 CHEMBL5183171 C-X-C chemokine receptor type 3 Human 1030 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595479&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 168283702 482606331 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477139 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)N1CCCC1)C(F)(F)F InChI=1S/C23H28F3N9OS/c1-14-12-33(8-9-34(14)18(36)13-35-16(3)29-15(2)31-35)20-19(30-21(37-20)23(24,25)26)17-10-27-22(28-11-17)32-6-4-5-7-32/h10-11,14H,4-9,12-13H2,1-3H3/t14-/m1/s1 DOGPUYUYHRIAAX-CQSZACIVSA-N 50595480 CHEMBL5206539 C-X-C chemokine receptor type 3 Human 523 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595480&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90479958 482606332 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477140 COc1ccc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H24F3N7O2S/c1-12-10-29(7-8-30(12)17(32)11-31-14(3)26-13(2)28-31)19-18(27-20(34-19)21(22,23)24)15-5-6-16(33-4)25-9-15/h5-6,9,12H,7-8,10-11H2,1-4H3/t12-/m1/s1 ICSXEIGDNSDUPH-GFCCVEGCSA-N 50595481 CHEMBL5181702 C-X-C chemokine receptor type 3 Human 1170 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595481&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480414 482606333 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477141 CCOc1ccc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C22H26F3N7O2S/c1-5-34-17-7-6-16(10-26-17)19-20(35-21(28-19)22(23,24)25)30-8-9-31(13(2)11-30)18(33)12-32-15(4)27-14(3)29-32/h6-7,10,13H,5,8-9,11-12H2,1-4H3/t13-/m1/s1 ZLQWYXVHVHGANW-CYBMUJFWSA-N 50595482 CHEMBL5208280 C-X-C chemokine receptor type 3 Human 505 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595482&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480413 482606334 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477142 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1ccc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C21H21F6N7OS/c1-11-9-32(6-7-33(11)16(35)10-34-13(3)29-12(2)31-34)18-17(30-19(36-18)21(25,26)27)14-4-5-15(28-8-14)20(22,23)24/h4-5,8,11H,6-7,9-10H2,1-3H3/t11-/m1/s1 DTKBGGWOJWTTBQ-LLVKDONJSA-N 50595483 CHEMBL5201967 C-X-C chemokine receptor type 3 Human 608 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595483&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 90480049 482606335 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477143 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(Br)nc1-c1nc2ccccc2[nH]1 InChI=1S/C23H21BrN8OS/c1-14-11-30(9-10-32(14)18(33)12-31-13-26-17-7-4-8-25-21(17)31)22-19(29-23(24)34-22)20-27-15-5-2-3-6-16(15)28-20/h2-8,13-14H,9-12H2,1H3,(H,27,28)/t14-/m1/s1 VSHOBSIPZJJYRP-CQSZACIVSA-N 208613 US9266876, 80 C-X-C chemokine receptor type 3 Human 126 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208613&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 89726625 328081720 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477144 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8OS/c1-10-8-32(4-5-33(10)14(35)9-34-12(3)29-11(2)31-34)16-15(30-18(36-16)20(24,25)26)13-6-27-17(28-7-13)19(21,22)23/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m1/s1 JENUMEXEVAAAJX-SNVBAGLBSA-N 50595484 CHEMBL5202301 C-X-C chemokine receptor type 3 Human 222 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595484&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 87056189 482606336 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477145 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1scnc1-c1nc2ccccc2[nH]1 InChI=1S/C23H22N8OS/c1-15-11-29(23-20(26-14-33-23)21-27-16-5-2-3-6-17(16)28-21)9-10-31(15)19(32)12-30-13-25-18-7-4-8-24-22(18)30/h2-8,13-15H,9-12H2,1H3,(H,27,28)/t15-/m1/s1 CCZJAXJXLVRTOE-OAHLLOKOSA-N 208550 US9266876, 17 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2200 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208550 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208550&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 71679630 328081658 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477146 C[C@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1scnc1-c1nc2ccccc2[nH]1 InChI=1S/C23H22N8OS/c1-15-11-29(23-20(26-14-33-23)21-27-16-5-2-3-6-17(16)28-21)9-10-31(15)19(32)12-30-13-25-18-7-4-8-24-22(18)30/h2-8,13-15H,9-12H2,1H3,(H,27,28)/t15-/m0/s1 CCZJAXJXLVRTOE-HNNXBMFYSA-N 208580 US9266876, 47 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 630 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208580 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208580&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 71680142 328081687 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477147 CC[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1scnc1-c1nc2ccccc2[nH]1 InChI=1S/C24H24N8OS/c1-2-16-12-30(24-21(27-15-34-24)22-28-17-6-3-4-7-18(17)29-22)10-11-32(16)20(33)13-31-14-26-19-8-5-9-25-23(19)31/h3-9,14-16H,2,10-13H2,1H3,(H,28,29)/t16-/m1/s1 AXOCJQGAWLLMQP-MRXNPFEDSA-N 208582 US9266876, 49 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 750 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208582 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208582&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 71680140 328081689 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477148 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(C)nc1-c1nc2ccccc2[nH]1 InChI=1S/C24H24N8OS/c1-15-12-30(10-11-32(15)20(33)13-31-14-26-19-8-5-9-25-23(19)31)24-21(27-16(2)34-24)22-28-17-6-3-4-7-18(17)29-22/h3-9,14-15H,10-13H2,1-2H3,(H,28,29)/t15-/m1/s1 CTUWPSNEZJLVDO-OAHLLOKOSA-N 208677 US9266876, 144 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2600 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208677 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208677&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 89726154 328081784 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477149 CCc1nc(-c2nc3ccccc3[nH]2)c(s1)N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12 InChI=1S/C25H26N8OS/c1-3-20-30-22(23-28-17-7-4-5-8-18(17)29-23)25(35-20)31-11-12-33(16(2)13-31)21(34)14-32-15-27-19-9-6-10-26-24(19)32/h4-10,15-16H,3,11-14H2,1-2H3,(H,28,29)/t16-/m1/s1 YVQHSLWAWYYPCD-MRXNPFEDSA-N 208679 US9266876, 146 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 960 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208679 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208679&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 89725785 328081786 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477150 CC(C)c1nc(-c2nc3ccccc3[nH]2)c(s1)N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12 InChI=1S/C26H28N8OS/c1-16(2)25-31-22(23-29-18-7-4-5-8-19(18)30-23)26(36-25)32-11-12-34(17(3)13-32)21(35)14-33-15-28-20-9-6-10-27-24(20)33/h4-10,15-17H,11-14H2,1-3H3,(H,29,30)/t17-/m1/s1 BEMATWPFDYPDGS-QGZVFWFLSA-N 208583 US9266876, 50 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1300 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208583 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208583&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 71680139 328081690 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477151 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1nc2ccccc2[nH]1)C1CC1 InChI=1S/C26H26N8OS/c1-16-13-32(11-12-34(16)21(35)14-33-15-28-20-7-4-10-27-24(20)33)26-22(31-25(36-26)17-8-9-17)23-29-18-5-2-3-6-19(18)30-23/h2-7,10,15-17H,8-9,11-14H2,1H3,(H,29,30)/t16-/m1/s1 NYCIVVXGRDGDMY-MRXNPFEDSA-N 208606 US9266876, 73 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 380 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208606 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208606&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 71678461 328081713 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477152 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(CO)nc1-c1nc2ccccc2[nH]1 InChI=1S/C24H24N8O2S/c1-15-11-30(9-10-32(15)20(34)12-31-14-26-18-7-4-8-25-23(18)31)24-21(29-19(13-33)35-24)22-27-16-5-2-3-6-17(16)28-22/h2-8,14-15,33H,9-13H2,1H3,(H,27,28)/t15-/m1/s1 GDZIMMMZJZDSBL-OAHLLOKOSA-N 208758 US9266876, 225 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 19000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208758 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208758&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 89726443 328081865 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477153 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1nc2ccccc2[nH]1)C1COC1 InChI=1S/C26H26N8O2S/c1-16-11-32(9-10-34(16)21(35)12-33-15-28-20-7-4-8-27-24(20)33)26-22(31-25(37-26)17-13-36-14-17)23-29-18-5-2-3-6-19(18)30-23/h2-8,15-17H,9-14H2,1H3,(H,29,30)/t16-/m1/s1 RWEYPYDCLNMMCX-MRXNPFEDSA-N 208646 US9266876, 113 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 4400 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208646 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208646&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 89726367 328081753 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477154 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(CN(C)C)nc1-c1nc2ccccc2[nH]1 InChI=1S/C26H29N9OS/c1-17-13-33(11-12-35(17)22(36)15-34-16-28-20-9-6-10-27-25(20)34)26-23(31-21(37-26)14-32(2)3)24-29-18-7-4-5-8-19(18)30-24/h4-10,16-17H,11-15H2,1-3H3,(H,29,30)/t17-/m1/s1 CJRBJYVXACGXMC-QGZVFWFLSA-N 208756 US9266876, 223 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208756 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208756&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 89726522 328081863 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477155 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1nc2ccccc2[nH]1)C(F)(F)F InChI=1S/C24H21F3N8OS/c1-14-11-33(9-10-35(14)18(36)12-34-13-29-17-7-4-8-28-21(17)34)22-19(32-23(37-22)24(25,26)27)20-30-15-5-2-3-6-16(15)31-20/h2-8,13-14H,9-12H2,1H3,(H,30,31)/t14-/m1/s1 ZXDZWWNBSQEKTQ-CQSZACIVSA-N 208584 US9266876, 51 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 1750 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208584 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208584&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 71679146 328081691 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477156 COc1ccc(cc1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C24H23F3N6O2S/c1-15-12-31(10-11-33(15)19(34)13-32-14-29-18-4-3-9-28-21(18)32)22-20(30-23(36-22)24(25,26)27)16-5-7-17(35-2)8-6-16/h3-9,14-15H,10-13H2,1-2H3/t15-/m1/s1 XIFXGXPXGJFERZ-OAHLLOKOSA-N 50595450 CHEMBL5194504 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 8800 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595450 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595450&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168284279 482606302 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477157 COc1ccc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C23H22F3N7O2S/c1-14-11-31(8-9-33(14)18(34)12-32-13-29-16-4-3-7-27-20(16)32)21-19(30-22(36-21)23(24,25)26)15-5-6-17(35-2)28-10-15/h3-7,10,13-14H,8-9,11-12H2,1-2H3/t14-/m1/s1 JACUNCNAGINCQW-CQSZACIVSA-N 50595451 CHEMBL5198351 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 8900 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595451 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595451&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168287733 482606303 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477158 COc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C22H21F3N8O2S/c1-13-10-31(6-7-33(13)16(34)11-32-12-29-15-4-3-5-26-18(15)32)19-17(30-20(36-19)22(23,24)25)14-8-27-21(35-2)28-9-14/h3-5,8-9,12-13H,6-7,10-11H2,1-2H3/t13-/m1/s1 OYWKHWVAFXYSMV-CYBMUJFWSA-N 50595452 CHEMBL5181928 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595452 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595452&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168273430 482606304 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477159 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C23H23F3N8O2S/c1-3-36-22-28-9-15(10-29-22)18-20(37-21(31-18)23(24,25)26)32-7-8-34(14(2)11-32)17(35)12-33-13-30-16-5-4-6-27-19(16)33/h4-6,9-10,13-14H,3,7-8,11-12H2,1-2H3/t14-/m1/s1 XBJUPTBJVOMJCO-CQSZACIVSA-N 50595453 CHEMBL5172053 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 13000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595453 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595453&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168270807 482606305 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477160 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1cnc(C)nc1)C(F)(F)F InChI=1S/C22H21F3N8OS/c1-13-10-31(6-7-33(13)17(34)11-32-12-29-16-4-3-5-26-19(16)32)20-18(15-8-27-14(2)28-9-15)30-21(35-20)22(23,24)25/h3-5,8-9,12-13H,6-7,10-11H2,1-2H3/t13-/m1/s1 VLHHCRXKWPFNLU-CYBMUJFWSA-N 50595454 CHEMBL5197065 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 15000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595454 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595454&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168288472 482606306 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477161 CCCc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C24H25F3N8OS/c1-3-5-18-29-10-16(11-30-18)20-22(37-23(32-20)24(25,26)27)33-8-9-35(15(2)12-33)19(36)13-34-14-31-17-6-4-7-28-21(17)34/h4,6-7,10-11,14-15H,3,5,8-9,12-13H2,1-2H3/t15-/m1/s1 SQIWTCCTICJGQD-OAHLLOKOSA-N 50595455 CHEMBL5177288 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 5900 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595455 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595455&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168276987 482606307 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477162 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(nc1-c1cnc(OCCN(C)C)nc1)C(F)(F)F InChI=1S/C25H28F3N9O2S/c1-16-13-35(7-8-37(16)19(38)14-36-15-32-18-5-4-6-29-21(18)36)22-20(33-23(40-22)25(26,27)28)17-11-30-24(31-12-17)39-10-9-34(2)3/h4-6,11-12,15-16H,7-10,13-14H2,1-3H3/t16-/m1/s1 SYQRCZRHRQEMDZ-MRXNPFEDSA-N 50595456 CHEMBL5208823 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595456 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595456&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168296640 482606308 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477163 COCCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2cccnc12)C(F)(F)F InChI=1S/C24H25F3N8O3S/c1-15-12-33(6-7-35(15)18(36)13-34-14-31-17-4-3-5-28-20(17)34)21-19(32-22(39-21)24(25,26)27)16-10-29-23(30-11-16)38-9-8-37-2/h3-5,10-11,14-15H,6-9,12-13H2,1-2H3/t15-/m1/s1 RYHBCLVDDXPZFW-OAHLLOKOSA-N 50595457 CHEMBL5192156 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595457 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595457&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168286958 482606309 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477164 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc2ccccc12)C(F)(F)F InChI=1S/C24H24F3N7O2S/c1-3-36-23-28-10-16(11-29-23)20-21(37-22(31-20)24(25,26)27)32-8-9-34(15(2)12-32)19(35)13-33-14-30-17-6-4-5-7-18(17)33/h4-7,10-11,14-15H,3,8-9,12-13H2,1-2H3/t15-/m1/s1 OLVSYMSHMPDLDC-OAHLLOKOSA-N 50595458 CHEMBL5185762 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 4700 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595458 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595458&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168282215 482606310 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477165 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc2cccnc12)C(F)(F)F InChI=1S/C24H24F3N7O2S/c1-3-36-23-29-11-17(12-30-23)19-21(37-22(31-19)24(25,26)27)33-9-10-34(15(2)13-33)18(35)14-32-8-6-16-5-4-7-28-20(16)32/h4-8,11-12,15H,3,9-10,13-14H2,1-2H3/t15-/m1/s1 RYGFAGJTSJALSV-OAHLLOKOSA-N 50595459 CHEMBL5169888 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 4200 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595459 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595459&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168269369 482606311 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477166 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc2cnccc12)C(F)(F)F InChI=1S/C24H24F3N7O2S/c1-3-36-23-29-11-17(12-30-23)20-21(37-22(31-20)24(25,26)27)33-8-9-34(15(2)13-33)19(35)14-32-7-5-16-10-28-6-4-18(16)32/h4-7,10-12,15H,3,8-9,13-14H2,1-2H3/t15-/m1/s1 JKXDGMZWBPPROG-OAHLLOKOSA-N 50595460 CHEMBL5177520 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 570 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595460 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595460&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168273685 482606312 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477167 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ncc2cccnc12)C(F)(F)F InChI=1S/C23H23F3N8O2S/c1-3-36-22-28-9-16(10-29-22)18-20(37-21(31-18)23(24,25)26)32-7-8-33(14(2)12-32)17(35)13-34-19-15(11-30-34)5-4-6-27-19/h4-6,9-11,14H,3,7-8,12-13H2,1-2H3/t14-/m1/s1 OHCHSHBZTNEQGO-CQSZACIVSA-N 50595461 CHEMBL5193608 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 15000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595461 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595461&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168285354 482606313 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477168 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)CN1C(=O)Cc2ccccc12)C(F)(F)F InChI=1S/C25H25F3N6O3S/c1-3-37-24-29-11-17(12-30-24)21-22(38-23(31-21)25(26,27)28)32-8-9-33(15(2)13-32)20(36)14-34-18-7-5-4-6-16(18)10-19(34)35/h4-7,11-12,15H,3,8-10,13-14H2,1-2H3/t15-/m1/s1 SMAFLQUUCFSCKQ-OAHLLOKOSA-N 50595462 CHEMBL5172352 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 3000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595462 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595462&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168269773 482606314 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477169 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1c2ccccc2oc1=O)C(F)(F)F InChI=1S/C24H23F3N6O4S/c1-3-36-22-28-10-15(11-29-22)19-20(38-21(30-19)24(25,26)27)31-8-9-32(14(2)12-31)18(34)13-33-16-6-4-5-7-17(16)37-23(33)35/h4-7,10-11,14H,3,8-9,12-13H2,1-2H3/t14-/m1/s1 BMVSBLODQFXGED-CQSZACIVSA-N 50595463 CHEMBL5200240 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2200 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595463 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595463&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168290539 482606315 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477170 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cccn1)C(F)(F)F InChI=1S/C20H22F3N7O2S/c1-3-32-19-24-9-14(10-25-19)16-17(33-18(27-16)20(21,22)23)28-7-8-30(13(2)11-28)15(31)12-29-6-4-5-26-29/h4-6,9-10,13H,3,7-8,11-12H2,1-2H3/t13-/m1/s1 SYIPMMMMYIYKNH-CYBMUJFWSA-N 50595464 CHEMBL5177069 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 19000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595464 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595464&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168272582 482606316 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477171 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nccc1C)C(F)(F)F InChI=1S/C21H24F3N7O2S/c1-4-33-20-25-9-15(10-26-20)17-18(34-19(28-17)21(22,23)24)29-7-8-30(14(3)11-29)16(32)12-31-13(2)5-6-27-31/h5-6,9-10,14H,4,7-8,11-12H2,1-3H3/t14-/m1/s1 SQQCZTRSSXULOZ-CQSZACIVSA-N 50595465 CHEMBL5190681 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 5600 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595465 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595465&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168280397 482606317 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477172 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc(C)n1)C(F)(F)F InChI=1S/C21H24F3N7O2S/c1-4-33-20-25-9-15(10-26-20)17-18(34-19(27-17)21(22,23)24)29-7-8-31(14(3)11-29)16(32)12-30-6-5-13(2)28-30/h5-6,9-10,14H,4,7-8,11-12H2,1-3H3/t14-/m1/s1 FNWYUHTYYMOKEC-CQSZACIVSA-N 50595466 CHEMBL5186167 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 13000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595466 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595466&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168279606 482606318 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477173 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)cc1C)C(F)(F)F InChI=1S/C22H26F3N7O2S/c1-5-34-21-26-9-16(10-27-21)18-19(35-20(28-18)22(23,24)25)30-6-7-31(15(4)11-30)17(33)12-32-14(3)8-13(2)29-32/h8-10,15H,5-7,11-12H2,1-4H3/t15-/m1/s1 OJXUXNMBYAVBNZ-OAHLLOKOSA-N 50595467 CHEMBL5186627 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 13000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595467 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595467&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168281055 482606319 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477174 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H25F3N8O2S/c1-5-34-20-25-8-15(9-26-20)17-18(35-19(28-17)21(22,23)24)30-6-7-31(12(2)10-30)16(33)11-32-14(4)27-13(3)29-32/h8-9,12H,5-7,10-11H2,1-4H3/t12-/m1/s1 NCYGASZSBZTJJB-GFCCVEGCSA-N 50595468 CHEMBL5190588 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595468&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 90480455 482606320 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477175 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1ccc(n1)C(F)(F)F)C(F)(F)F InChI=1S/C21H21F6N7O2S/c1-3-36-19-28-8-13(9-29-19)16-17(37-18(30-16)21(25,26)27)32-6-7-34(12(2)10-32)15(35)11-33-5-4-14(31-33)20(22,23)24/h4-5,8-9,12H,3,6-7,10-11H2,1-2H3/t12-/m1/s1 QSPYPBJJEIJUBY-GFCCVEGCSA-N 50595469 CHEMBL5187464 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 5100 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595469 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595469&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168282319 482606321 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477176 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cnc(n1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8O2S/c1-3-36-18-27-6-12(7-28-18)14-15(37-17(30-14)20(24,25)26)32-4-5-34(11(2)8-32)13(35)9-33-10-29-16(31-33)19(21,22)23/h6-7,10-11H,3-5,8-9H2,1-2H3/t11-/m1/s1 CQKKTUGMIMJTHL-LLVKDONJSA-N 50595470 CHEMBL5197175 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >6000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595470 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595470&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168287236 482606322 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477177 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1cc(Cl)cn1)C(F)(F)F InChI=1S/C20H21ClF3N7O2S/c1-3-33-19-25-6-13(7-26-19)16-17(34-18(28-16)20(22,23)24)29-4-5-31(12(2)9-29)15(32)11-30-10-14(21)8-27-30/h6-8,10,12H,3-5,9,11H2,1-2H3/t12-/m1/s1 PCGSLLVSTSRSKW-GFCCVEGCSA-N 50595471 CHEMBL5193432 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 2800 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595471 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595471&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168289637 482606323 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477178 COc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C20H23F3N8O2S/c1-11-9-29(5-6-30(11)15(32)10-31-13(3)26-12(2)28-31)17-16(27-18(34-17)20(21,22)23)14-7-24-19(33-4)25-8-14/h7-8,11H,5-6,9-10H2,1-4H3/t11-/m1/s1 BEGJXZQGVNJUBB-LLVKDONJSA-N 50595472 CHEMBL5181086 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595472 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595472&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 90479922 482606324 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477179 CC(C)Oc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C22H27F3N8O2S/c1-12(2)35-21-26-8-16(9-27-21)18-19(36-20(29-18)22(23,24)25)31-6-7-32(13(3)10-31)17(34)11-33-15(5)28-14(4)30-33/h8-9,12-13H,6-7,10-11H2,1-5H3/t13-/m1/s1 FSVSKYZTMULUBO-CYBMUJFWSA-N 50595473 CHEMBL5175118 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595473 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595473&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 90479878 482606325 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477180 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(OC2CCC2)nc1)C(F)(F)F InChI=1S/C23H27F3N8O2S/c1-13-11-32(7-8-33(13)18(35)12-34-15(3)29-14(2)31-34)20-19(30-21(37-20)23(24,25)26)16-9-27-22(28-10-16)36-17-5-4-6-17/h9-10,13,17H,4-8,11-12H2,1-3H3/t13-/m1/s1 UYHRPCZNDBJPKM-CYBMUJFWSA-N 50595474 CHEMBL5203452 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595474 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595474&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 90479960 482606326 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477181 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(C)nc1)C(F)(F)F InChI=1S/C20H23F3N8OS/c1-11-9-29(5-6-30(11)16(32)10-31-14(4)26-13(3)28-31)18-17(15-7-24-12(2)25-8-15)27-19(33-18)20(21,22)23/h7-8,11H,5-6,9-10H2,1-4H3/t11-/m1/s1 MAXPGZIREDSCQL-LLVKDONJSA-N 50595475 CHEMBL5192208 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595475 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595475&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 90479919 482606327 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477182 CCc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H25F3N8OS/c1-5-16-25-8-15(9-26-16)18-19(34-20(28-18)21(22,23)24)30-6-7-31(12(2)10-30)17(33)11-32-14(4)27-13(3)29-32/h8-9,12H,5-7,10-11H2,1-4H3/t12-/m1/s1 IZNYLAAYGQFRQK-GFCCVEGCSA-N 50595476 CHEMBL5183818 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595476 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595476&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 90480006 482606328 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477183 CCCc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C22H27F3N8OS/c1-5-6-17-26-9-16(10-27-17)19-20(35-21(29-19)22(23,24)25)31-7-8-32(13(2)11-31)18(34)12-33-15(4)28-14(3)30-33/h9-10,13H,5-8,11-12H2,1-4H3/t13-/m1/s1 PKMSGXKNNBJYJW-CYBMUJFWSA-N 50595477 CHEMBL5195689 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595477 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595477&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 90480457 482606329 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477184 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C1CC1)C(F)(F)F InChI=1S/C22H25F3N8OS/c1-12-10-31(6-7-32(12)17(34)11-33-14(3)28-13(2)30-33)20-18(29-21(35-20)22(23,24)25)16-8-26-19(27-9-16)15-4-5-15/h8-9,12,15H,4-7,10-11H2,1-3H3/t12-/m1/s1 ITBVWHCXAKEDFM-GFCCVEGCSA-N 50595478 CHEMBL5205683 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 13000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595478 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595478&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 90479923 482606330 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477185 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C(C)(C)C)C(F)(F)F InChI=1S/C23H29F3N8OS/c1-13-11-32(7-8-33(13)17(35)12-34-15(3)29-14(2)31-34)19-18(30-21(36-19)23(24,25)26)16-9-27-20(28-10-16)22(4,5)6/h9-10,13H,7-8,11-12H2,1-6H3/t13-/m1/s1 JSLHIASGSJBGLL-CYBMUJFWSA-N 50595479 CHEMBL5183171 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595479 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595479&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 168283702 482606331 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477186 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)N1CCCC1)C(F)(F)F InChI=1S/C23H28F3N9OS/c1-14-12-33(8-9-34(14)18(36)13-35-16(3)29-15(2)31-35)20-19(30-21(37-20)23(24,25)26)17-10-27-22(28-11-17)32-6-4-5-7-32/h10-11,14H,4-9,12-13H2,1-3H3/t14-/m1/s1 DOGPUYUYHRIAAX-CQSZACIVSA-N 50595480 CHEMBL5206539 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595480 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595480&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 90479958 482606332 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477187 COc1ccc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H24F3N7O2S/c1-12-10-29(7-8-30(12)17(32)11-31-14(3)26-13(2)28-31)19-18(27-20(34-19)21(22,23)24)15-5-6-16(33-4)25-9-15/h5-6,9,12H,7-8,10-11H2,1-4H3/t12-/m1/s1 ICSXEIGDNSDUPH-GFCCVEGCSA-N 50595481 CHEMBL5181702 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595481 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595481&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 90480414 482606333 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477188 CCOc1ccc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C22H26F3N7O2S/c1-5-34-17-7-6-16(10-26-17)19-20(35-21(28-19)22(23,24)25)30-8-9-31(13(2)11-30)18(33)12-32-15(4)27-14(3)29-32/h6-7,10,13H,5,8-9,11-12H2,1-4H3/t13-/m1/s1 ZLQWYXVHVHGANW-CYBMUJFWSA-N 50595482 CHEMBL5208280 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595482 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595482&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 90480413 482606334 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477189 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1ccc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C21H21F6N7OS/c1-11-9-32(6-7-33(11)16(35)10-34-13(3)29-12(2)31-34)18-17(30-19(36-18)21(25,26)27)14-4-5-15(28-8-14)20(22,23)24/h4-5,8,11H,6-7,9-10H2,1-3H3/t11-/m1/s1 DTKBGGWOJWTTBQ-LLVKDONJSA-N 50595483 CHEMBL5201967 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 5200 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595483 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595483&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 90480049 482606335 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477190 C[C@@H]1CN(CCN1C(=O)Cn1cnc2cccnc12)c1sc(Br)nc1-c1nc2ccccc2[nH]1 InChI=1S/C23H21BrN8OS/c1-14-11-30(9-10-32(14)18(33)12-31-13-26-17-7-4-8-25-21(17)31)22-19(29-23(24)34-22)20-27-15-5-2-3-6-16(15)28-20/h2-8,13-14H,9-12H2,1H3,(H,27,28)/t14-/m1/s1 VSHOBSIPZJJYRP-CQSZACIVSA-N 208613 US9266876, 80 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 340 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=208613 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=208613&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 89726625 328081720 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477191 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8OS/c1-10-8-32(4-5-33(10)14(35)9-34-12(3)29-11(2)31-34)16-15(30-18(36-16)20(24,25)26)13-6-27-17(28-7-13)19(21,22)23/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m1/s1 JENUMEXEVAAAJX-SNVBAGLBSA-N 50595484 CHEMBL5202301 Potassium voltage-gated channel subfamily H member 2 Homo sapiens >20000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595484&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 87056189 482606336 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477192 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8OS/c1-10-8-32(4-5-33(10)14(35)9-34-12(3)29-11(2)31-34)16-15(30-18(36-16)20(24,25)26)13-6-27-17(28-7-13)19(21,22)23/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m1/s1 JENUMEXEVAAAJX-SNVBAGLBSA-N 50595484 CHEMBL5202301 C-X-C chemokine receptor type 3 Mus musculus 1.8 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=50003604&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595484&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 87056189 482606336 1 MYLEVSERQVLDASDFAFLLENSTSPYDYGENESDFSDSPPCPQDFSLNFDRTFLPALYSLLFLLGLLGNGAVAAVLLSQRTALSSTDTFLLHLAVADVLLVLTLPLWAVDAAVQWVFGPGLCKVAGALFNINFYAGAFLLACISFDRYLSIVHATQIYRRDPRVRVALTCIVVWGLCLLFALPDFIYLSANYDQRLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRFRAMRLVVVVVAAFAVCWTPYHLVVLVDILMDVGVLARNCGRESHVDVAKSVTSGMGYMHCCLNPLLYAFVGVKFREQMWMLFTRLGRSDQRGPQRQPSSSRRESSWSETTEASYLGL C-X-C chemokine receptor type 3 CXCR3_MOUSE O88410 Q4V9Y6 Q9QWN6 51477193 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8OS/c1-10-8-32(4-5-33(10)14(35)9-34-12(3)29-11(2)31-34)16-15(30-18(36-16)20(24,25)26)13-6-27-17(28-7-13)19(21,22)23/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m1/s1 JENUMEXEVAAAJX-SNVBAGLBSA-N 50595484 CHEMBL5202301 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 18000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595484&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 87056189 482606336 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477194 CCOc1ncc(cn1)-c1nc(sc1N1CCN([C@H](C)C1)C(=O)Cn1nc(C)nc1C)C(F)(F)F InChI=1S/C21H25F3N8O2S/c1-5-34-20-25-8-15(9-26-20)17-18(35-19(28-17)21(22,23)24)30-6-7-31(12(2)10-30)16(33)11-32-14(4)27-13(3)29-32/h8-9,12H,5-7,10-11H2,1-4H3/t12-/m1/s1 NCYGASZSBZTJJB-GFCCVEGCSA-N 50595468 CHEMBL5190588 Potassium voltage-gated channel subfamily H member 2 Homo sapiens 44000 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595468 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=2132&target=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595468&enzyme=Potassium+voltage-gated+channel+subfamily+H+member+2&column=ki&startPg=0&Increment=50&submit=Search 90480455 482606320 1 MPVRRGHVAPQNTFLDTIIRKFEGQSRKFIIANARVENCAVIYCNDGFCELCGYSRAEVMQRPCTCDFLHGPRTQRRAAAQIAQALLGAEERKVEIAFYRKDGSCFLCLVDVVPVKNEDGAVIMFILNFEVVMEKDMVGSPAHDTNHRGPPTSWLAPGRAKTFRLKLPALLALTARESSVRSGGAGGAGAPGAVVVDVDLTPAAPSSESLALDEVTAMDNHVAGLGPAEERRALVGPGSPPRSAPGQLPSPRAHSLNPDASGSSCSLARTRSRESCASVRRASSADDIEAMRAGVLPPPPRHASTGAMHPLRSGLLNSTSDSDLVRYRTISKIPQITLNFVDLKGDPFLASPTSDREIIAPKIKERTHNVTEKVTQVLSLGADVLPEYKLQAPRIHRWTILHYSPFKAVWDWLILLLVIYTAVFTPYSAAFLLKETEEGPPATECGYACQPLAVVDLIVDIMFIVDILINFRTTYVNANEEVVSHPGRIAVHYFKGWFLIDMVAAIPFDLLIFGSGSEELIGLLKTARLLRLVRVARKLDRYSEYGAAVLFLLMCTFALIAHWLACIWYAIGNMEQPHMDSRIGWLHNLGDQIGKPYNSSGLGGPSIKDKYVTALYFTFSSLTSVGFGNVSPNTNSEKIFSICVMLIGSLMYASIFGNVSAIIQRLYSGTARYHTQMLRVREFIRFHQIPNPLRQRLEEYFQHAWSYTNGIDMNAVLKGFPECLQADICLHLNRSLLQHCKPFRGATKGCLRALAMKFKTTHAPPGDTLVHAGDLLTALYFISRGSIEILRGDVVVAILGKNDIFGEPLNLYARPGKSNGDVRALTYCDLHKIHRDDLLEVLDMYPEFSDHFWSSLEITFNLRDTNMIPGSPGSTELEGGFSRQRKRKLSFRRRTDKDTEQPGEVSALGPGRAGAGPSSRGRPGGPWGESPSSGPSSPESSEDEGPGRSSSPLRLVPFSSPRPPGEPPGGEPLMEDCEKSSDTCNPLSGAFSGVSNIFSFWGDSRGRQYQELPRCPAPTPSLLNIPLSSPGRRPRGDVESRLDALQRQLNRLETRLSADMATVLQLLQRQMTLVPPAYSAVTTPGPGPTSTSPLLPVSPLPTLTLDSLSQVSQFMACEELPPGAPELPQEGPTRRLSLPGQLGALTSQPLHRHGSDPGS 1UJL,2L0W,2L4R,2N7G,4HQA,5VA1,5VA2,5VA3,6SYG,7CN0,7CN1 Potassium voltage-gated channel subfamily H member 2 KCNH2_HUMAN Q12809 A5H1P7 C4PFH9 D3DX04 O75418 O75680 Q708S9 Q9BT72 Q9BUT7 Q9H3P0 Potassium voltage-gated channel subfamily H member 2 A0A090N8Q0_HUMAN A0A090N8Q0 51477195 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8OS/c1-10-8-32(4-5-33(10)14(35)9-34-12(3)29-11(2)31-34)16-15(30-18(36-16)20(24,25)26)13-6-27-17(28-7-13)19(21,22)23/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m1/s1 JENUMEXEVAAAJX-SNVBAGLBSA-N 50595484 CHEMBL5202301 C-X-C chemokine receptor type 3 Human 3.8 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595484&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 87056189 482606336 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477196 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8OS/c1-10-8-32(4-5-33(10)14(35)9-34-12(3)29-11(2)31-34)16-15(30-18(36-16)20(24,25)26)13-6-27-17(28-7-13)19(21,22)23/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m1/s1 JENUMEXEVAAAJX-SNVBAGLBSA-N 50595484 CHEMBL5202301 C-X-C chemokine receptor type 3 Human 2.7 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595484&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 87056189 482606336 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5 51477197 C[C@@H]1CN(CCN1C(=O)Cn1nc(C)nc1C)c1sc(nc1-c1cnc(nc1)C(F)(F)F)C(F)(F)F InChI=1S/C20H20F6N8OS/c1-10-8-32(4-5-33(10)14(35)9-34-12(3)29-11(2)31-34)16-15(30-18(36-16)20(24,25)26)13-6-27-17(28-7-13)19(21,22)23/h6-7,10H,4-5,8-9H2,1-3H3/t10-/m1/s1 JENUMEXEVAAAJX-SNVBAGLBSA-N 50595484 CHEMBL5202301 C-X-C chemokine receptor type 3 Human 3.4 ChEMBL 10.7270/Q29K4G85 35947786 Meyer, EA; Äänismaa, P; Froidevaux, S; Keller, M; Piali, L; Caroff, E 9/8/2022 6/21/2023 Idorsia Pharmaceuticals Ltd. http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50595484 http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=pol&polymerid=402&target=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search http://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?energyterm=kJ/mole&tag=r21&monomerid=50595484&enzyme=C-X-C+chemokine+receptor+type+3&column=ki&startPg=0&Increment=50&submit=Search 87056189 482606336 1 MVLEVSDHQVLNDAEVAALLENFSSSYDYGENESDSCCTSPPCPQDFSLNFDRAFLPALYSLLFLLGLLGNGAVAAVLLSRRTALSSTDTFLLHLAVADTLLVLTLPLWAVDAAVQWVFGSGLCKVAGALFNINFYAGALLLACISFDRYLNIVHATQLYRRGPPARVTLTCLAVWGLCLLFALPDFIFLSAHHDERLNATHCQYNFPQVGRTALRVLQLVAGFLLPLLVMAYCYAHILAVLLVSRGQRRLRAMRLVVVVVVAFALCWTPYHLVVLVDILMDLGALARNCGRESRVDVAKSVTSGLGYMHCCLNPLLYAFVGVKFRERMWMLLLRLGCPNQRGLQRQPSSSRRDSSWSETSEASYSGL C-X-C chemokine receptor type 3 CXCR3_HUMAN P49682 B2R982 O15185 Q7Z710 Q9P2T4 Q9P2T5